HOUSTON, Aug. 31, 2026 /PRNewswire/ — Summit Midstream Corporation (NYSE: SMC) (“Summit”, “SMC” or the “Company”) announced today that Double E Pipeline, LLC (“Double E”) has concluded a successful open season and reached a final investment decision on its previously announced mainline compression expansion project, supported by a new long-term firm transportation agreement with an investment-grade shipper.
Highlights
Reached a final investment decision on the mainline compression expansion, with an expected in-service date in the fourth quarter of 2028
Executed a new long-term take-or-pay firm transportation agreement with an investment-grade shipper for 200 MMcf/d, bringing total contracted firm capacity on Double E to approximately 2.2 Bcf/d
Converted the $50 million uncommitted accordion at Summit Permian Transmission to committed, bringing total committed financing capacity to $100 million and fully funding Summit’s expected Double E capital contributions
Robust future growth opportunities associated with data center developments in Texas and New Mexico and connectivity with additional egress pipelines
Management Commentary
Heath Deneke, President, Chief Executive Officer and Chairman, commented, “Today’s announcement is a significant milestone for Summit and Double E and further demonstrates the importance of the pipeline to producers and processors in the Delaware Basin. Double E provides reliable gas transmission service with access to multiple downstream markets, and we continue to expand that connectivity as the basin grows. The strong shipper interest we have seen through the open season reinforces the value of that position and our confidence in the long-term growth opportunity for Double E.
“The open season resulted in 550 MMcf/d of new long-term take-or-pay commitments which underpinned the final investment decision to move forward with the compression expansion and we continue to advance discussions with multiple shippers to subscribe the remaining 450 MMcf/d of incremental forward haul capacity. With these newly signed contracts, we expect to invest approximately $100 million, net to Summit’s 70% interest, to install the mainline compression station, incremental plant connections and related infrastructure, all of which will be funded entirely with the previously announced term loan at Summit Permian Transmission and the now-committed $50 million accordion. We continue to see tremendous production growth surrounding our Delaware Basin operating footprint and fully expect to enter into long-term contracts for the remaining expansion capacity in the coming months. When the project is fully subscribed, we expect our Permian Segment Adjusted EBITDA to grow from approximately $37 million in 2026 to over $100 million by 2030.”
“As we look into the future for the Double E Pipeline beyond filling the mainline compression expansion capacity to Waha, we are very excited about a new phase of demand-pull growth opportunities that are emerging from data center development in Texas and New Mexico as well as additional egress pipelines that are hungry for enhanced access to Permian gas supply. With our connectivity to numerous gas processing facilities in the basin and the Waha Hub, we are incredibly well positioned to attract those markets to the Double E Pipeline and leverage the bi-directional capability of the system to nearly double the outlook for the business in the years ahead.”
Double E Mainline Compression Expansion
The expansion project consists of the installation of a bi-directional mainline compressor station on the Double E system, which will increase the pipeline’s forward haul capacity to Waha by approximately 900 MMcf/d. The compression project along with new plant connections and related infrastructure is expected to cost approximately $100 million net to Summit’s 70% interest and is expected to be placed in service by the fourth quarter of 2028.
The Double E joint venture has already placed a purchase order for the long-lead gas turbine compression units required for the project, securing manufacturing slots necessary to support the targeted in-service date. The project remains subject to FERC and other customary regulatory approvals.
With the new 200 MMcf/d agreement, Double E has secured approximately 550 MMcf/d of binding long-term take-or-pay commitments through the compression expansion open season. Total contracted firm capacity on the pipeline is now approximately 2.2 Bcf/d, held by a diversified group of primarily investment-grade shippers. Double E continues to advance discussions with additional prospective shippers regarding remaining capacity on the expansion.
Summit Permian Transmission Financing
In connection with the final investment decision, Summit Permian Transmission converted the previously uncommitted $50 million accordion under its existing $440 million senior secured term facility maturing in March 2031 into a committed facility. Combined with the $50 million committed delayed draw term facility established at closing in March 2026, Summit expects to have sufficient commitments to fund all of its expected capital contributions to Double E over the next several years. The Summit Permian Transmission term facility remains non-recourse to SMC.
About Double E Pipeline, LLC
Double E is a 135-mile FERC-regulated interstate natural gas transmission pipeline that commenced operations in November 2021 and provides transportation service from receipt points in the Delaware Basin to various delivery points in and around the Waha Hub in Texas.
Double E is owned by subsidiaries of Summit Midstream Corporation (NYSE: SMC) and ExxonMobil (NYSE: XOM) with an ownership interest of 70% and 30%, respectively. Summit Midstream Permian II, LLC is the operator of Double E.
About Summit Midstream Corporation
SMC is a value-driven corporation focused on developing, owning and operating midstream energy infrastructure assets that are strategically located in the core producing areas of unconventional resource basins, primarily shale formations, in the continental United States. SMC provides natural gas, crude oil and produced water gathering, processing and transportation services pursuant to primarily long-term, fee-based agreements with customers and counterparties in five unconventional resource basins: (i) the Williston Basin, which includes the Bakken and Three Forks shale formations in North Dakota; (ii) the Denver-Julesburg Basin, which includes the Niobrara and Codell shale formations in Colorado and Wyoming; (iii) the Fort Worth Basin, which includes the Barnett Shale formation in Texas; (iv) the Arkoma Basin, which includes the Woodford and Caney shale formations in Oklahoma; and (v) the Piceance Basin, which includes the Mesaverde formation as well as the Mancos and Niobrara shale formations in Colorado. SMC has an equity method investment in Double E Pipeline, LLC, which provides interstate natural gas transportation service from multiple receipt points in the Delaware Basin to various delivery points in and around the Waha Hub in Texas. SMC is headquartered in Houston, Texas.
Forward-Looking Statements
This press release includes certain statements concerning expectations for the future that are forward-looking within the meaning of the federal securities laws. Forward-looking statements include, without limitation, any statement that may project, indicate or imply future results, events, performance or achievements and may contain the words “expect,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “will be,” “will continue,” “will likely result,” and similar expressions, or future conditional verbs such as “may,” “will,” “should,” “would” and “could.” In addition, any statement concerning future financial performance (including future revenues, earnings or growth rates), payment of dividends on any series of stock, ongoing business strategies and possible actions taken by SMC or its subsidiaries are also forward-looking statements. Forward-looking statements also contain known and unknown risks and uncertainties (many of which are difficult to predict and beyond management’s control) that may cause SMC’s actual results in future periods to differ materially from anticipated or projected results. An extensive list of specific material risks and uncertainties affecting SMC is contained in its 2025 Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on March 16, 2026, as amended and updated from time to time. Any forward-looking statements in this press release are made as of the date of this press release and SMC undertakes no obligation to update or revise any forward-looking statements to reflect new information or events.
Engagement set to mark the first delivery of Majestic.ai as customer-operated licensed software, adding a software licensing model to Tiltan’s project-based services
NEW YORK and NETANYA, Israel, Aug. 26, 2026 (GLOBE NEWSWIRE) — T3 Defense Inc. (Nasdaq: DFNS) (“T3 Defense” or the “Company”), today announced that its wholly owned subsidiary, Tiltan Software Engineering Ltd. (“Tiltan”), has been selected by a sensor systems developer and manufacturer to license Majestic.ai, Tiltan’s generative artificial intelligence (AI) synthetic data platform. This marks the first time Majestic.ai will be delivered as software the customer operates itself, rather than as a service Tiltan performs.
Majestic.ai
Majestic.ai is Tiltan’s AI platform for synthetic data generation. The physics-based platform produces labeled image and video datasets that defense customers use to train and validate AI systems when real world data is costly or impossible to collect. The platform covers electro-optical (EO), infrared (IR), light detection and ranging (LiDAR), and synthetic aperture radar (SAR) across land, maritime, air, and space environments, and also supports sensor and hardware development programs.
To date, Majestic.ai has been sold as a managed service, with Tiltan producing each dataset for the customer. This engagement is set to mark the platform’s first delivery as licensed software operated by the customer. Management believes a licensed model can support more repeatable revenue per customer and allow Tiltan to serve more programs without adding project labor for each one.
The Majestic.ai license will be paired with Tiltan’s T-VERSE geospatial 3D content, so the customer receives both the generation engine and the underlying data. Bundling the two also gives Tiltan a second product to attach to future licenses.
Management Commentary
“Synthetic data has become one of the constraints on how quickly advanced sensors and AI systems can be developed and fielded,” said Menny Shalom, Chairman and Chief Executive Officer of T3 Defense. “Tiltan has spent years producing that data for its customers. Licensing Majestic.ai puts the engine, and the content behind it, directly into the customer’s hands. That is a different business than project-by-project services, and we believe it is a meaningful step towards a more scalable, repeatable revenue source from the AI and simulation assets we already own.”
“Our customers must train and validate systems against conditions they cannot practically capture in the field,” said Ehud Shafir, Chief Executive Officer of Tiltan. “With Majestic.ai delivered as licensed software and paired with T-VERSE content, this customer will be able to generate the volume of datasets it needs on its required schedules. Being selected for the first engagement of this kind validates the maturity of the platform and the demand for customer-operated synthetic data generation.”
Commercial Status
The Company is not disclosing the value, scope, or customer identity of the engagement. Majestic.ai has not yet been delivered under this engagement and no revenue has been recognized to date. There can be no assurance as to the timing of delivery, the amount or timing of any revenue recognition, the customer’s continued use or expansion of the license, or that the engagement will result in additional licensed-software programs with this or any other customer.
About Tiltan Software Engineering Ltd.
Tiltan Software Engineering Ltd., a wholly owned subsidiary of T3 Defense, is a leading solution provider specializing in simulation, 3D engines, generative AI training, geo-systems, 3D content, and operations center systems and tools. With over 30 years of experience, Tiltan’s simulation products provide a comprehensive one-stop solution for training, development, and hardware-in-the-loop systems, powered by a proprietary 3D engine and generative AI. Tiltan’s geo-system products support space, aerial, manned, and unmanned vehicles, addressing registration, localization, and navigation challenges, as well as geo-mapping systems. Its in-house content production delivers high-fidelity, geo-specific visual databases, 3D models, and mapping data for VIS, IR, LiDAR, and SAR applications. For more information, visit www.tiltan-se.com.
About T3 Defense Inc.
T3 Defense Inc. (Nasdaq: DFNS) is a defense company that acquires and operates mission-critical defense businesses involved in national security programs. It focuses on manufacturers with strong customer relationships and solid order backlogs, often capacity- and resource-constrained, in specialized areas such as drones and autonomous vehicles, counter-drone systems, advanced manufacturing, tactical robotics, and AI software and system integration. Through disciplined acquisitions, centralized capital and strategy, and decentralized day-to-day operations, T3 Defense aims to strengthen essential defense capabilities and build long-term value. For more information, visit www.t3dfns.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are forward-looking statements, including, without limitation, statements regarding Tiltan’s selection to deliver Majestic.ai as a licensed software product; the expectation that the engagement will mark the first delivery of Majestic.ai in a self-service, customer-operated model; the anticipated capabilities, configurations, and performance of Majestic.ai and T-VERSE; the timing or completion of delivery; expected demand for licensed, customer-operated synthetic data generation; the potential for additional orders, licenses, production programs, or recurring revenue; the potential for integration across T3 Defense’s portfolio companies; and the Company’s growth strategy. These statements are based on management’s current expectations and assumptions and involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied, including risks related to the absence of executed follow-on orders for the licensed model described herein; delivery, integration, and customer acceptance risk; market adoption and customer qualification and testing requirements; defense program funding, procurement cycles, and timing; dependence on government contracts and defense OEM relationships; protection of intellectual property in a licensed-software model; customer concentration; competitive and geopolitical conditions, including conditions in Israel; the Company’s liquidity and capital resources; the Company’s ability to maintain compliance with Nasdaq listing requirements; integration of acquired businesses; and other risks described in the Company’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. Forward-looking statements speak only as of the date of this release, and the Company undertakes no obligation to update or revise them, except as required by law.
SHELTON, CT / ACCESS Newswire / August 31, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, provides an update on its Measles Drug Treatment Program.
While CDC is reviewing the two recent measles-related fatalities in Pennsylvania, the total number of confirmed measles cases in the USA has reached 2,903 as of August 27, 2026, in comparison to 2,289 confirmed cases in the whole year of 2025, indicating continuing expansion of measles1. Cases of Measles have been rising globally for different reasons. The measles outbreak in Bangladesh has continued to proliferate, claiming 19,218 confirmed cases with 99 fatalities in confirmed cases from 15 March to 30 August, 2026. During this period, a total of 1,37,347 patients with suspected measles were admitted to hospitals and 868 children have died of suspected measles, whereas 1,151 suspected measles cases with 4 deaths were reported in just the last 24 hours in Bangladesh2. The measles outbreak in Bangladesh has continued despite aggressive vaccination campaign that was undertaken since April-May 2026.
In the USA, since COVID-19 days, the MMR vaccination rate has fallen from 95.2% in 2019-2020 to an average of 92.4% in 2025-26, which can be clearly ascribed to the general public vaccine hesitancy that has resulted from the aggressive COVID vaccination policies. The current MMR vaccination rate is well below the 95% putative threshold that is generally agreed as necessary to block spread of measles, with approximately 280,000 unvaccinated kindergartners at risk of measles, according to CDC (ibid #1). The rate of “breakthrough” measles cases in the USA has remained steady at about 6% (~3% in single dose and ~3% in full 2-dose vaccinated individuals) (CDC data).
There is currently no approved drug for measles. Vaccine does not help a patient already infected with the measles virus. Vaccinating already measles-exposed persons to avoid disease spread is attempted yet measles has continued to spread in the USA.
Thus an effective treatment for Measles is an unmet medical need. NV-387 is the only drug candidate to our knowledge that has demonstrated strong in vivo activity against lethal infection with the Measles virus in a humanized animal model study.
NanoViricides is currently developing a Phase II clinical trial protocol for evaluating NV-387 as a treatment for measles. A draft is being circulated. The Company intends to bring this protocol under the purview of the US FDA in an IND process. Therefore, this work is expected to take some time.
NV-387 has been granted a “Rare Pediatric Disease Drug” (RPDD) Designation by the US FDA Office of Orphan Products Development (OOPD).
This RPDD designation enables that a Priority Review Voucher (PRV) can be issued to the Company upon a successful Marketing Application (i.e. New Drug Application) for the use of NV-387 as a treatment for Measles, provided all of the required conditions are met.
The Company can use the PRV, if granted, to reduce review times on another of its drug applications. Importantly, a PRV can be sold to another Pharma Company for accelerating their drug program as well, which provides a high value to the purchaser. Recently, a PRV has been sold for $195 Million3.
Sale of a PRV can bring cash to the Company even prior to revenues from commercialization of a drug product.
“The Rare Pediatric Disease Drug Designation and associated Priority Review Voucher that can be issued make a strong business case for development of NV-387 as a drug for the treatment of Measles,” said Anil R. Diwan, PhD., adding, “NV-387, as an effective drug would be an important tool to fight Measles resurgence in the USA and worldwide, when approved.”
FDA has granted both ODD and RPDD for NV-387 as a Treatment of Measles.
In addition to the PRV eligibility provided by the RPDD for NV-387 as a treatment of Measles, the Orphan Drug Designation qualifies NanoViricides for incentives including:
Tax credits for qualified clinical trials;
Exemption from certain user fees;
Potential seven years of market exclusivity after approval;
according to the US FDA4.
Measles continues to be a rare disease in the USA, with annual incidence rates well below 200,000 cases. Measles primarily affects children. These facts have qualified NV-387 for Measles Treatment for an Orphan Drug Designation, and also for a Rare Pediatric Disease Drug Designation. In a rare disease scenario, commercial revenue from the drug may be slow and small. The PRV is designed to incentivize drug development for rare pediatric diseases by providing additional business value.
Measles cases are rising across the Western world including several European countries and the UK, as well as the USA and Canada. Additionally Mexico and several other Central and South American countries have also been suffering from rising Measles outbreaks.
Measles is endemic globally; many countries that had achieved an elimination status for Measles have by now lost this status, due to severe outbreaks over the last three years5.
Measles is a highly contagious disease, and spreads via virus particles in bodily fluids upon close contact. A population vaccination rate of at least 95% is required to provide “herd immunity” and block community spread. Such a high rate is difficult to maintain for several reasons. Firstly, vaccine hesitancy is rising globally. Secondly, persons with co-morbidities such as immune-compromise status, diabetes, obesity, etc. do not respond fully to any vaccination. Even if vaccinated, such a person can still get Measles, suffering from possibly a mild disease, but will still be contagious and spread Measles. Additionally, the Measles virus continues to change, with the B and D genotypes in circulation currently, while the vaccines in use are still the ones developed for the A genotype in the 1960’s.
Further, very high rates of infections in vaccinated subjects (called “breakthrough cases”), from 14% to 57%, have occurred in some outbreaks6 suggesting that resistant virus strains may have been involved.
Therefore, an effective treatment for Measles is an unmet medical need, that is expected to become even more important in the near future than it is today. Only an effective treatment can help the patient and can avoid the potential severe disease scenarios such as encephalitis, neurological disabilities, and potential fatalities as well as immune amnesia that can result from severe disease.
Quicker recovery of a patient means less chances for spread and thus better ability to control an outbreak. This would require an effective treatment.
NV-387 is an extremely broad-spectrum antiviral drug that has demonstrated strong effectiveness in relevant animal models of multiple human viral infections. These include RSV, COVID, Influenza, Mpox, Smallpox, and Measles.
NanoViricides, Inc. (the “Company”) (www.nanoviricides.com) is a publicly traded (NYSE-American, stock symbol NNVC) clinical stage company that is creating special purpose nanomaterials for antiviral therapy. The Company’s novel nanoviricide™ class of drug candidates and the nanoviricide™ technology are based on intellectual property, technology and proprietary know-how of TheraCour Pharma, Inc. The Company has a Memorandum of Understanding with TheraCour for the development of drugs based on these technologies for all antiviral infections. The MoU does not include cancer and similar diseases that may have viral origin but require different kinds of treatments.
The Company has obtained broad, exclusive, sub-licensable, field licenses to drugs developed in several licensed fields from TheraCour Pharma, Inc. The Company’s business model is based on licensing technology from TheraCour Pharma Inc. for specific application verticals of specific viruses, as established at its foundation in 2005.
Our lead drug candidate is NV-387, a broad-spectrum antiviral drug that we plan to develop as a treatment of RSV, COVID, Long COVID, Influenza, and other respiratory viral infections, as well as MPOX/Smallpox infections. Our other advanced drug candidate is NV-HHV-1 for the treatment of Shingles. The Company cannot project an exact date for filing an IND for any of its drugs because of dependence on a number of external collaborators and consultants. The Company is currently focused on advancing NV-387 into Phase II human clinical trials.
The Company is also developing drugs against a number of viral diseases including oral and genital Herpes, viral diseases of the eye including EKC and herpes keratitis, H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others. NanoViricides’ platform technology and programs are based on the TheraCour® nanomedicine technology of TheraCour, which TheraCour licenses from AllExcel. NanoViricides holds a worldwide exclusive perpetual license to this technology for several drugs with specific targeting mechanisms in perpetuity for the treatment of the following human viral diseases: Human Immunodeficiency Virus (HIV/AIDS), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Rabies, Herpes Simplex Virus (HSV-1 and HSV-2), Varicella-Zoster Virus (VZV), Influenza and Asian Bird Flu Virus, Dengue viruses, Japanese Encephalitis virus, West Nile Virus, Ebola/Marburg viruses, and certain Coronaviruses. The Company intends to obtain a license for RSV, Poxviruses, and/or Enteroviruses if the initial research is successful. As is customary, the Company must state the risk factor that the path to typical drug development of any pharmaceutical product is extremely lengthy and requires substantial capital. As with any drug development efforts by any company, there can be no assurance at this time that any of the Company’s pharmaceutical candidates would show sufficient effectiveness and safety for human clinical development. Further, there can be no assurance at this time that successful results against coronavirus in our lab will lead to successful clinical trials or a successful pharmaceutical product.
This press release contains forward-looking statements that reflect the Company’s current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by NanoViricides, Inc. are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company’s control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company’s expectations include, but are not limited to, those factors that are disclosed under the heading “Risk Factors” and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities. Although it is not possible to predict or identify all such factors, they may include the following: demonstration and proof of principle in preclinical trials that a nanoviricide is safe and effective; successful development of our product candidates; our ability to seek and obtain regulatory approvals, including with respect to the indications we are seeking; the successful commercialization of our product candidates; and market acceptance of our products.
The phrases “safety”, “effectiveness” and equivalent phrases as used in this press release refer to research findings including clinical trials as the customary research usage and do not indicate evaluation of safety or effectiveness by the US FDA.
FDA refers to US Food and Drug Administration. IND application refers to “Investigational New Drug” application. cGMP refers to current Good Manufacturing Practices. CMC refers to “Chemistry, Manufacture, and Controls”. CHMP refers to the Committee for Medicinal Products for Human Use, which is the European Medicines Agency’s (EMA) committee responsible for human medicines. API stands for “Active Pharmaceutical Ingredient”. WHO is the World Health Organization. R&D refers to Research and Development.
Oil prices surged Monday after the United States and Iran exchanged direct military fire for the first time in roughly a month, ending a relatively quiet stretch in a war now entering its seventh month. Brent crude futures climbed to an intraday high above $91 a barrel, gaining roughly 3% to cross $90 for the first time in about a week, while US benchmark WTI crude gained roughly 4% to trade above $86.
The exchange began when US forces struck Iranian targets on Larak Island, a small landmass inside the Strait of Hormuz that functions as a key monitoring point for Iran’s Revolutionary Guard Corps. US Central Command said the strikes targeted launchers it believed were being prepared to fire rockets carrying sea mines into the strait. Iran retaliated with drone strikes on sites inside Jordan and the United Arab Emirates and said it had seized a bulk carrier vessel near the port of Bandar Abbas. Tehran also claimed an oil tanker struck a mine while attempting an unauthorized transit through the strait, though US Central Command stated it had already cleared that section of the waterway.
Even with this renewed exchange, the physical oil market tells a more nuanced story than headline crude prices alone. Goldman Sachs estimates Persian Gulf crude exports have recovered to roughly two-thirds of pre-war levels, near 15 million barrels per day. The more persistent constraint now sits downstream, in refined products like gasoline and diesel, where capacity has been squeezed by Iranian strikes on regional refineries and, separately, Ukrainian strikes on Russian refining infrastructure. Goldman’s commodities strategists now expect global refined product output to decline by roughly 7 million barrels per day, a constraint that keeps pressure on fuel prices even as crude export volumes have partially normalized.
The policy response is shifting as well. Treasury Secretary Scott Bessent has threatened severe economic consequences for any nation found doing business with Tehran, signaling a pivot from direct military engagement toward economic pressure as the primary tool going forward. Last week, Treasury sanctioned the Emirati branches of a major Egyptian bank it accused of funneling roughly $1.8 billion to the Iranian regime. Critics of that approach note such measures carry limited practical impact unless they eventually target China, which continues purchasing an estimated 90% of Iran’s crude exports. A senior UAE foreign policy adviser put the broader dilemma plainly this week, noting that a state of neither war nor peace cannot be a sustainable solution.
For investors, the national average price of gasoline sitting at $4.08 a gallon despite recent modest declines is worth watching closely, both for its direct effect on consumer-facing small caps already navigating tight household budgets, a dynamic we detailed in earlier coverage of the ceasefire’s collapse, and for its political relevance heading into US midterm elections roughly two months away, where fuel affordability is likely to factor into races that will determine control of Congress. With refined product capacity constrained independent of crude export volumes, sustained pressure on pump prices may persist even if this latest exchange does not escalate further.
Federal Reserve Chair Kevin Warsh gave his first major speech as chair on Friday at the Fed’s annual Jackson Hole gathering, and the tone caught markets off guard. Warsh said inflation remains above the Fed’s target and that fighting price pressure needs to stay the Fed’s top priority right now. Investors had hoped for some hint of a coming rate cut or at least a softer tone. They got neither. All three major stock indexes closed lower after his remarks, and traders quickly raised the odds of a rate hike at the Fed’s September meeting to nearly 61%.
The bigger story is what happened in the bond market afterward. The 30-year Treasury yield has climbed since Warsh spoke Friday, pushing back toward 5.27%, close to the high that rattled markets in late July and led the Treasury Department to step in and buy back more bonds to calm things down, a move we detailed closely at the time. Part of Monday’s move also came from oil prices jumping after renewed fighting between the US and Iran over the weekend.
Here is the part worth understanding clearly. When long-term Treasury yields rise, it usually means one of two things is happening, either investors expect higher inflation ahead, or they simply want more return for tying up their money for 30 years, regardless of inflation. Right now, it is almost entirely the second reason. Expectations for long-term inflation have barely moved, and have actually ticked down slightly. Investors are not panicking about inflation over the next three decades. They are just demanding a higher price to hold long-term government debt, a shift that can be driven by how much the government is borrowing, how fast the economy is expected to grow, or simply less certainty about where policy is headed. Warsh himself hinted at this Friday, saying he would be hard-pressed to call current financial conditions restrictive, a comment that leaves plenty of room for long-term rates to keep climbing even without the Fed making another official move.
That makes 5.3% the level worth watching most closely. A sustained move above it would push borrowing costs back into the same territory that unsettled markets last month.
For companies operating below the $2 billion market cap threshold, this distinction matters. Small and microcap companies typically carry more variable-rate debt than large companies, so their borrowing costs are especially sensitive to moves like this. If rising rates are being driven by investors simply wanting more compensation to hold long-term debt, rather than fear of runaway inflation, that pressure may prove harder to ease with a single Fed decision than markets first assumed when Warsh took over.
DeepSeek founder Liang Wenfeng’s hedge fund, High-Flyer Quant, has built pre-IPO positions in several of China’s most closely watched technology listings this year, including memory chipmaker CXMT and humanoid robot maker Unitree Robotics.
Two High-Flyer affiliates, Zhejiang High-Flyer Asset Management and Ningbo High-Flyer Quantitative Investment Management, took positions across a range of sectors ahead of these companies’ public debuts, spanning chip packaging, electronic components, renewable energy, and semiconductor supply-chain businesses. Nearly half of the funds’ allocations this year went to semiconductors and related supply-chain companies.
CXMT was the largest single position, with the two funds holding a combined pre-IPO stake estimated at $26 million. The stock surged 466% on its Shanghai debut last month, briefly making it China’s most valuable listed company, and has gained an additional 20% since then.
The funds also held a pre-IPO stake in Unitree Robotics estimated at $5.8 million. Unitree closed 460% above its IPO price on its first day of trading in Shanghai last week, though the stock has since fallen back about 27% from that peak.
DeepSeek itself took a separate and distinct position in Unitree, acquiring a 2.31% strategic allocation and agreeing to a 36-month lock-up period, three times longer than the 12-month hold most other strategic investors accepted in the same deal. This reflects a different objective than High-Flyer’s approach: DeepSeek’s stake functions as a long-term strategic holding tied to its position in the broader AI supply chain, while High-Flyer’s stake was structured as a return-seeking investment.
These pre-IPO opportunities have emerged in part because Beijing has been encouraging strategically important technology companies to list domestically rather than overseas, creating an environment where funds positioned early in sectors aligned with state industrial priorities, such as semiconductors and robotics, have captured outsized returns.
The strategy has carried real risk. During a global AI-chip selloff in July, only one of High-Flyer’s nine investment products avoided losses that month, according to state-backed media reporting. Chinese quant funds broadly recovered those losses by August.
Separately, DeepSeek’s own capital needs have grown substantially and now diverge sharply from High-Flyer’s scale. DeepSeek opened itself to outside investors for the first time this year, raising 50 billion yuan in its initial funding round, an amount exceeding half of High-Flyer’s total assets under management of 80 billion yuan. DeepSeek is reportedly now in discussions to raise at least $7.4 billion more in a second funding round, which would value the company at $74 billion. High-Flyer and DeepSeek did not respond to requests for comment on these transactions.
The Russell 2000 is having a year most investors thought they’d never see again. After more than a decade of trailing large-cap stocks, the small-cap benchmark has turned in its best first-half performance in 35 years, gaining about 22% by the midpoint of 2026 and outperforming the Nasdaq by roughly nine percentage points. For a market that has spent years defined by a handful of mega-cap tech names, that’s a meaningful shift in leadership. Here’s the case for why it may have room to continue.
The valuation gap is still historically wide. Even after the rally, small-cap stocks continue to trade at a discount to large caps, despite the gap narrowing in recent months. Some strategists put numbers on that gap directly: the Russell 2000 trades at its cheapest level relative to the Russell 1000 in 25 years. Cheap valuations alone don’t guarantee outperformance, but they mean small caps aren’t rallying from a stretched starting point the way parts of the large-cap market are.
Rate relief is doing real work. Small companies tend to carry more floating-rate debt than their large-cap peers, which makes them more sensitive to the direction of interest rates. Analysts have pointed to the lagged benefits of Federal Reserve rate cuts from late 2025, which have eased financial pressures on companies carrying floating-rate debt, as a real tailwind behind this year’s move. Lower borrowing costs flow through to smaller-company balance sheets faster and more directly than they do for cash-rich mega-caps.
The rally is broadening, not narrowing. Rather than a rotation away from AI, strategists have framed this move as a broadening of market participation beyond the small group of companies that have driven the market for years. Some analysts go further, arguing the market is now rewarding AI exposure more than current earnings, with unprofitable small caps leading their profitable peers — a sign investors are hunting for the next layer of AI beneficiaries beyond the Magnificent Seven.
There’s also a domestic and macro angle. Part of the appeal is that small caps carry less exposure to global trade tensions and mega-cap concentration risk, making them a relatively direct way to bet on U.S. economic resilience rather than global supply chains or a handful of concentrated tech bets.
The case isn’t unanimous.Not every strategist is convinced this is durable. Wolfe Research, for one, has attributed early-2026 strength largely to technical factors, including seasonal flows, year-end asset reallocation and a January reversal following tax-loss selling, and the firm’s stated view has been to “sell the rip in small caps and stick with large-cap leadership” rather than chase the move. That’s a useful reminder that a valuation discount and a rate tailwind don’t eliminate the sector’s historically higher volatility.
The bottom line is small caps enter the back half of 2026 with a rare combination — a historically wide valuation discount, a genuine rate tailwind, and a market that appears to be broadening its search for growth beyond mega-cap tech. Whether that turns into a multi-year cycle of outperformance or proves to be a technical catch-up trade will likely hinge on two things worth watching closely: whether the Fed continues easing, and whether small-cap earnings growth starts catching up to the price action that’s already happened.
Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.
George Proost, Research Associate, Noble Capital Markets, Inc.
Refer to the full report for the price target, fundamental analysis, and rating.
A multi-brand platform expansion. On August 24, the company completed the acquisition of Drake’s October’s Very Own (OVO) operating business, including its 12 stores, e-commerce platform, wholesale relationships, employees, assets, and liabilities across Canada, the United States, and the United Kingdom.
Acquisition details. OVO’s intellectual property was valued at approximately $117.6 million, with Authentic Brands Group owning 51%, Drake retaining 44%, and Vince purchasing the remaining 5% for $6 million. A portion of the proceeds from the IP sale was used to repay OVO’s debt and provide additional liquidity for its operating business, which Vince acquired for a nominal equity price of $3.
Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.
This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).
*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.
Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.
Jacob Mutchler, Research Analyst, Noble Capital Markets, Inc.
Refer to the full report for the price target, fundamental analysis, and rating.
A softer finish to the year. The company reported Q4 revenue of $303.9 million, modestly below our estimate of $314.0 million, while adj. EBITDA of $74.1 million missed our $88.0 million estimate by nearly 16%. Management attributed the revenue softness to unfavorable weather at its largest water parks and high viewership of the World Cup and NBA Finals.
June weighed on results. Management estimated the sports-related revenue impact at $7 million to $12 million and the incremental weather impact on the water parks at $3 million to $5 million. Despite these pressures, the underlying trends were stronger than the quarterly results suggest. Full-year same-store sales declined just 0.2%, marking the company’s best comp since fiscal 2023.
Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.
This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).
*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.
Noble Capital Markets Research Report Friday, August 28, 2026
Companies contained in today’s report:
Lucky Strike Entertainment (LUCK)/OUTPERFORM – From Investment To Cash Flow Vince Holding Corp. (VNCE)/OUTPERFORM – OVO Acquisition Establishes Multi-Brand Platform
Lucky Strike Entertainment (LUCK/$6.26 | Price Target: $14.5) Michael Kupinski [email protected] | (561) 994-5734 Jacob Mutchler [email protected] | From Investment To Cash Flow Rating: OUTPERFORM
A softer finish to the year. The company reported Q4 revenue of $303.9 million, modestly below our estimate of $314.0 million, while adj. EBITDA of $74.1 million missed our $88.0 million estimate by nearly 16%. Management attributed the revenue softness to unfavorable weather at its largest water parks and high viewership of the World Cup and NBA Finals.
June weighed on results. Management estimated the sports-related revenue impact at $7 million to $12 million and the incremental weather impact on the water parks at $3 million to $5 million. Despite these pressures, the underlying trends were stronger than the quarterly results suggest. Full-year same-store sales declined just 0.2%, marking the company’s best comp since fiscal 2023.
Vince Holding Corp. (VNCE/$7.81 | Price Target: $9) Michael Kupinski [email protected] | (561) 994-5734 George Proost [email protected] | OVO Acquisition Establishes Multi-Brand Platform Rating: OUTPERFORM
A multi-brand platform expansion. On August 24, the company completed the acquisition of Drake’s October’s Very Own (OVO) operating business, including its 12 stores, e-commerce platform, wholesale relationships, employees, assets, and liabilities across Canada, the United States, and the United Kingdom.
Acquisition details. OVO’s intellectual property was valued at approximately $117.6 million, with Authentic Brands Group owning 51%, Drake retaining 44%, and Vince purchasing the remaining 5% for $6 million. A portion of the proceeds from the IP sale was used to repay OVO’s debt and provide additional liquidity for its operating business, which Vince acquired for a nominal equity price of $3.
Noble Capital Markets Research Report Thursday, August 27, 2026
Companies contained in today’s report:
Direct Digital Holdings (DRCT)/MARKET PERFORM – Liquidity Overshadows Underlying Stability
Direct Digital Holdings (DRCT/$2.34) Michael Kupinski [email protected] | (561) 994-5734 George Proost [email protected] | Liquidity Overshadows Underlying Stability Rating: MARKET PERFORM
Q2 results. Second-quarter revenue of $7.8 million declined 23% year over year and came in 11% below our $8.8 million estimate. The shortfall was concentrated among demand-side platform customers, with spending falling to zero from $2.5 million in the prior-year quarter. Excluding DSP customers, revenue grew 3% in the quarter and 5% year-to-date, suggesting the core managed-campaign business is roughly stable even as the reported line contracts.
Gross margin held with disciplined spending. Gross profit of $2.7 million represented 34% of revenue, down modestly from 35% a year ago and flat with the first quarter. Operating expenses of $5.6 million declined 7% year over year. The adjusted EBITDA loss widened to $2.3 million from $1.5 million a year earlier, well short of our $0.35 million loss estimate, and management’s second-half breakeven target now looks difficult to reach.
Noble Capital Markets Research Report Wednesday, August 26, 2026
Companies contained in today’s report:
GDEV (GDEV)/OUTPERFORM – Profitability Outpaces Growth As Bookings Soften SelectQuote (SLQT)/OUTPERFORM – Cash Flow Inflection Takes Center Stage Tectonic Metals Inc. (TETOF)/OUTPERFORM – Black Creek Emerges as a Second Gold Center
GDEV (GDEV/$10.8 | Price Target: $70) Michael Kupinski [email protected] | (561) 994-5734 Jacob Mutchler [email protected] | Profitability Outpaces Growth As Bookings Soften Rating: OUTPERFORM
Q2 Results. GDEV reported Q2 revenue of $93.6 million, down 22%, and adj. EBITDA of $20.1 million, only down 7% year over year. Notably, the year-over-year revenue decrease was primarily driven by a decline in bookings. As illustrated in Figure #1 Q2 Results, both revenue and adj. EBITDA missed our estimates of $115 million and $26 million, respectively, though adj. EBITDA proved far more resilient than revenue.
Marketing discipline held margins. That resilience was largely due to lower selling and marketing expenses, which fell 38% to $32.7 million from $52.5 million, lifting the adj. EBITDA margin to roughly 21% from 18% even as revenue declined. The reduction stems from the company’s more disciplined strategy for user acquisition, which focuses on higher-value cohorts rather than volume.
SelectQuote (SLQT/$0.55 | Price Target: $3) Michael Kupinski [email protected] | (561) 994-5734 Jacob Mutchler [email protected] | Cash Flow Inflection Takes Center Stage Rating: OUTPERFORM
Q4 profitability improves despite softer revenue. Fiscal fourth quarter revenue declined 7% to $321.7 million from $345.1 million in the prior-year period, while adj. EBITDA increased to $11.9 million from $2.7 million. Operating cash usage also improved sharply to $3.3 million from $37.5 million a year earlier, highlighting the company’s improving cash conversion.
Healthcare Services emerges as a key earnings driver. Healthcare Services generated Q4 revenue of $193.5 million and adj. EBITDA of $12.1 million, with SelectRx membership of approximately 109,000. Importantly, prescription utilization continues to increase even as membership growth moderates, while the Olathe facility provides capacity for more than 200,000 members and meaningful opportunity for additional operating leverage.
Tectonic Metals Inc. (TETOF/$1.98 | Price Target: $3.5) Mark Reichman [email protected] | (561) 999-2272 Black Creek Emerges as a Second Gold Center Rating: OUTPERFORM
Flat is advancing rapidly. Tectonic is executing a five-rig, 40,000-meter drilling program at its flagship Flat Gold Project, with the primary objective of supporting a maiden NI 43-101 mineral resource estimate at Chicken Mountain in early 2027. The program is also targeting higher-grade mineralization and testing additional district-scale targets. The Chicken Mountain–Alpha Bowl system has already been traced for approximately 3.3 kilometers.
Black Creek is emerging as a second gold center. Tectonic released assay results from three holes drilled at the Black Creek target, including two reverse circulation and one diamond drill hole. Hole CMR26-152 returned 5.09 g/t gold over 21.34 meters, including 17.34 g/t over 6.10 meters. Hole CMR26-153 intersected a broader interval of 1.89 g/t over 57.91 meters, including 2.75 g/t over 38.10 meters, with higher-grade intervals of 6.31 g/t over 7.62 meters and 3.89 g/t over 6.10 meters. Diamond hole CMD26-041 returned 3.26 g/t over 5.06 meters and a deeper interval grading 16.73 g/t over 2.22 meters, including 29.91 g/t over 1.22 meters. Importantly, both RC holes ended in mineralization, indicating that the system remains open thus providing clear targets for deeper follow-up drilling.
Noble Capital Markets Research Report Tuesday, August 25, 2026
Companies contained in today’s report:
First Phosphate Corp. (PHOS)/OUTPERFORM – Definitive Mineral Resource Supports Transition to Feasibility Resolution Minerals Ltd (RLMLF)/OUTPERFORM – Initial Assays Return Significant Gold Mineralization
First Phosphate Corp. (PHOS/$17.1 | Price Target: $25.5) Mark Reichman [email protected] | (561) 999-2272 Definitive Mineral Resource Supports Transition to Feasibility Rating: OUTPERFORM
A stronger resource supports the transition to feasibility. First Phosphate’s definitive NI 43-101 report confirms approximately 204.7 million tonnes of measured and indicated resources grading roughly 6.05% phosphorus pentoxide (P2O5), including a 378% increase in indicated resources. Strong geological continuity, favorable metallurgy, and additional expansion potential at depth provide a stronger foundation for the Begin-Lamarche feasibility study.
The focus is shifting toward project development. With resource drilling mostly completed, First Phosphate is targeting completion of the feasibility study around January or February 2027, followed by permitting, financing, and a potential final investment decision. Development risk is further reduced by definitive offtake agreements, Canadian government funding, and potential international financing support.
Golden Gate South Discovery. Resolution Minerals confirmed a significant near-surface gold discovery at Golden Gate South within its 100%-owned Horse Heaven Antimony-Tungsten-Gold-Silver Project in Idaho. All three initial 2026 diamond holes intersected broad gold mineralization, extending the known mineralized system at least 2,000 meters south from Golden Gate North. The results, combined with gold-in-soil anomalies between the two areas, strengthen the potential that Golden Gate North and South are part of a much larger mineralized system along the Golden Gate Fault Zone.
Broad Gold Intercepts. The most significant hole, HH-GG26-003C, returned 305.7 meters grading 0.64 g/t gold from surface to the end of the hole, including several higher-grade zones of up to 17.25 meters at 1.19 g/t gold. The other two holes also encountered broad near-surface mineralization, including 87.87 meters at 0.52 g/t and 49.5 meters at 0.58 g/t gold. Collectively, the results are important because they demonstrate substantial widths of pervasive gold mineralization rather than isolated narrow intercepts, although additional drilling is required to establish true widths, continuity, and ultimately the potential size of the system.
Noble Capital Markets Research Report Monday, August 24, 2026
Companies contained in today’s report:
Newsmax (NMAX)/OUTPERFORM – Higher-Margin Revenue Streams Lift Earnings Outlook Radio Broadcast Industry (Radio Broadcast) – Radio at an Inflection Point Sky Harbour Group (SKYH)/OUTPERFORM – Increases Registered Direct Offering by $10 Million T3 Defense (DFNS)/OUTPERFORM – Reports 2Q26 Results Titan International (TWI)/OUTPERFORM – Highlights from Deere’s 3Q26 Conference Call
Newsmax (NMAX/$10.75 | Price Target: $17) Michael Kupinski [email protected] | (561) 994-5734 George Proost [email protected] | Higher-Margin Revenue Streams Lift Earnings Outlook Rating: OUTPERFORM
Record-Breaking Q2. The company reported its highest quarterly revenue of $54.1 million, up a solid 16.5% YoY, and adj. EBTDA of $5.7 million, both of which beat our estimates of $52.5 million and a loss of $0.675 million, respectively. Notably, the company generated its first profitable quarter as a public company, driven primarily by higher affiliate fees and licensing revenue.
Higher-margin revenue streams gaining momentum. Affiliate fee revenue increased 81.9% to $13.4 million, while licensing revenue increased 563.5% to $4.6 million. In our view, continued affiliate repricing and licensing growth should improve the company’s revenue mix and provide an increasingly important driver of margin expansion.
Radio Broadcast Industry Michael Kupinski [email protected] | (561) 994-5734 George Proost [email protected] | Radio at an Inflection Point
Radio’s audience remains considerably more resilient than its advertising performance suggests. Consumer engagement has held up far better than traditional spot revenue, even as podcasts, streaming, and other audio alternatives have proliferated. This disconnect is central to the investment thesis: radio increasingly has a monetization problem rather than an audience problem, creating an opportunity if technology can narrow the gap.
The industry’s transformation is increasingly becoming an ad-tech and digital monetization story. Programmatic buying, improved attribution, first-party data, podcasts, and digital marketing services are expanding radio beyond the traditional station-and-spot model. The opportunity is to use radio’s existing reach, content, and advertiser relationships to participate in a much larger advertising market rather than simply defend its share of traditional radio spending.
Sky Harbour Group (SKYH/$10.45 | Price Target: $23) Joe Gomes [email protected] | 561-999-2262 Increases Registered Direct Offering by $10 Million Rating: OUTPERFORM
Upsized. Sky Harbour executed a third stock purchase agreement under its Registered Direct common stock placement. An additional one million shares were sold to M-Cor Capital at $10 per share, raising an additional $10 million on top of the original $40 million raised. We anticipate the additional capital to be used to support future hangar developments.
Portfolio I. Sky Harbour filed its monthly Construction Report for July 2026. The Company continued to make progress in June on its two remaining projects from the Obligated Group (PABs 2021 Series bond issue) – Opa Locka Phase 2 (OPF2) in Opa Locka, FL and Addison Phase 2 (ADS2) in Addison, TX. At OPF2, Alston Construction is substantially complete with construction. Temporary Certificates of Occupancy (TCO) have been issued for all hangars and the GSE. Tenants have started moving into the hangars, and the campus is in full operation. At ADS2 (Addison Airport), Ascend Aviation continues to work towards completion of the Earthwork and Utility scopes of work, with all site sanitary and water completed. The airside apron stabilization is completed, with 8 of 12 pours complete. All foundation piers have been completed on all hangars.
T3 Defense (DFNS/$20.61 | Price Target: $30) Joe Gomes [email protected] | 561-999-2262 Reports 2Q26 Results Rating: OUTPERFORM
Overview. T3 Defense filed its 10Q for the quarter ended June 30, 2026. The Company did not issue a press release on the quarterly results, nor did management hold a conference call. Revenue came in below our expectations, but gross margin and operating loss were better than expected. Non-cash items significantly impacted the bottom line. We hope to speak with management shortly to provide a deeper review of the quarter and update our models.
2Q26 Results. Revenue was $4.0 million, below our $4.5 million projection. Gross margin was 25.4% exceeding our 11.1% estimate. T3 reported an operating loss of $3.4 million compared to our projection of a $3.9 million loss. Net loss from continuing operations was $85.7 million and net loss was $81.4 million. T3 reported a loss per share of $182.80 (adjusted for the recent 1-for-125 reverse stock split).
Titan International (TWI/$7.15 | Price Target: $11) Joe Gomes [email protected] | 561-999-2262 Highlights from Deere’s 3Q26 Conference Call Rating: OUTPERFORM
Deere Call. We reviewed Deere’s (NYSE:DE) 3Q26 results and conference call. Selling into Titan’s key end markets of Agriculture, Construction, and Consumer, Deere’s forward commentary can give a solid overview of Titan’s end markets and potential for improvement. Based on Deere’s comments, 2027 should show improvement across the board for Titan.
Construction. Order books for 2026 are largely full as demand fundamentals remain favorable across both the earthmoving and road building end markets. Large-scale infrastructure projects, data center construction, and pipeline activity continue to support robust customer demand. As a result, customer backlogs now extend well into fiscal year 2027, providing healthy visibility and optimism for next year.
Q2 and 1H FY 2026 Financial Performance. Kuya Silver generated Q2 FY 2026 revenue of $1,252,925, compared with $1,163,673 in the prior-year period. The company reported a net loss of $1,529,381, or $(0.01) per share, compared with a net loss of $282,559, or $(0.00) per share, in Q2 of FY 2025. During the 1H of FY 2026, revenue totaled $2,717,922, compared with $1,389,670 during the same period in FY 2025. The 1H net loss increased to $2,766,547, or $(0.01) per share, from $1,631,545, or $(0.01) per share, in the 1H of FY 2025. The greater loss reflected increased activity at the Bethania mine associated with the production ramp-up, as well as higher administrative expenses as Kuya expanded the organizational structure and capabilities required to support its growing operations. Increases in these line items were partially offset by higher revenue from Bethania and lower exploration and evaluation expenses.
Operational Momentum. Kuya continues to add contractors at the Bethania mine to augment its workforce, which is expected to accelerate mine development and underground drilling productivity during the remainder of the year. The mine team has initiated a focused development program and is allocating additional resources to unlock mineralized material for mining later in 2026 and into 2027. Key underground development initiatives, including construction of a new ramp and ore-handling systems to support the Phase 1 expansion to 350 tonnes per day, are progressing and are expected to improve operational stability and long-term production capacity.
Snail (SNAL/$2.89 | Price Target: $17.5) Michael Kupinski [email protected] | (561) 994-5734 George Proost [email protected] | Gamescom Lineup Puts the Non-ARK Pipeline on Display Rating: OUTPERFORM
Gamescom 2026 AAA unveiling. Snail announced its Gamescom 2026 lineup, headlined by the unveiling of its second internally developed AAA title in the 9 Yin Sutra universe, set in a parallel timeline and alternate universe to 9Yin Sutra: Immortal, which debuted at ChinaJoy on July 30th. In our note on August 12th, we had identified an unannounced AAA reveal at Gamescom as a near-term event, and the release confirms it.
The franchise builds. Both 9 Yin Sutra titles draw on the established Age of Wushu IP, offering different treatments of the same martial arts setting. Along with these titles, Snail will also show For The Stars, its space-survival AAA project. In our view, concentrating two out of the three AAA projects within a single IP family should improve development and marketing efficiency, while also making outcomes across those titles more correlated.
Noble Capital Markets Research Report Thursday, August 20, 2026
Companies contained in today’s report:
GDEV (GDEV)/OUTPERFORM – Profitability Momentum In Focus Ahead Of Q2 Results
GDEV (GDEV/$10.67 | Price Target: $70) Michael Kupinski [email protected] | (561) 994-5734 Jacob Mutchler [email protected] | Profitability Momentum In Focus Ahead Of Q2 Results Rating: OUTPERFORM
Q2 results preview. We expect GDEV’s second-quarter results to reflect continued disciplined user acquisition spending and a focus on profitable growth. For context, Q1 revenue increased 2% to $99 million, while adjusted EBITDA increased 15% to $18 million, benefiting from a 13% decline in selling and marketing expense, as illustrated in Figure #1 Q1 Results. The return to top-line growth, following a revenue decline in fiscal 2025, is encouraging.
Facing a difficult revenue comparison. Q2 will lap a relatively strong year-ago quarter, when revenue increased 13% to $120 million, driven in part by elevated performance marketing investment. As such, we believe the more important read-through will be the company’s ability to sustain engagement and monetization while maintaining its more disciplined approach to marketing expenditures.
Noble Capital Markets Research Report Wednesday, August 19, 2026
Companies contained in today’s report:
VivoPower International PLC (VIVO)/OUTPERFORM – De-Risked Nordic AI Infrastructure Pure-Play
VivoPower International PLC (VIVO/$4.4 | Price Target: $10) Michael Kupinski [email protected] | (561) 994-5734 George Proost [email protected] | De-Risked Nordic AI Infrastructure Pure-Play Rating: OUTPERFORM
Shareholder debt fully retired, materially improving credit quality. On August 3, 2026, VivoPower eliminated 100% of its $28.8m shareholder debt principal owed to AWN Holdings. $16.5 million was converted under PIPE 2 and $12.3 million was repaid in cash. The move removes the associated interest expense and materially improves credit quality ahead of the Nordic AI buildout, leaving no principal obligation to AWN.
PIPE secured to fund the AI conversion. A $50 million PIPE priced at US$7.50 per share on July 29, 2026, was led by Blue Sky Capital, alongside Nordic, EU, and GCC institutional and family-office investors. Proceeds are directed at the Mo i Rana AI data center conversion in Norway and further debt reduction.
Noble Capital Markets Research Report Tuesday, August 18, 2026
Companies contained in today’s report:
QuoteMedia Inc. (QMCI)/OUTPERFORM – Double-Digit Revenue Growth, Improving Margins Signal Operating Leverage Xerox Holdings Corporation (XRX)/OUTPERFORM – Reinvention Creates a Path to Sustainable Earnings Growth
QuoteMedia Inc. (QMCI/$0.15 | Price Target: $0.2) Michael Kupinski [email protected] | (561) 994-5734 George Proost [email protected] | Double-Digit Revenue Growth, Improving Margins Signal Operating Leverage Rating: OUTPERFORM
Solid Q2 revenue growth. QuoteMedia reported Q2 revenue of $5.45 million, up 11% YoY from $4.93 million, although below our $5.63 million estimate. The quarter marked the company’s second consecutive quarter of double-digit revenue growth, supported by new client wins and expansion within existing enterprise relationships.
Improving profitability. Gross margin increased to 50% from 46% in the year-earlier period, while adj. EBITDA increased to $241,000 from $99,000. The net loss narrowed substantially to $362,000 from $854,000. We believe the improving results provide early evidence of the operating leverage inherent in the company’s business model.
Xerox Holdings Corporation (XRX/$2.95 | Price Target: $5) Michael Kupinski [email protected] | (561) 994-5734 Jacob Mutchler [email protected] | Reinvention Creates a Path to Sustainable Earnings Growth Rating: OUTPERFORM
Initiating coverage with an Outperform rating and a $5 price target. Our constructive view reflects the company’s multiyear transformation through the Lexmark acquisition, expansion of IT Solutions and Digital Services, and continued focus on operating efficiency. We believe these initiatives can moderate revenue declines, improve profitability and cash generation, and ultimately support a multiyear earnings recovery and valuation re-rating.
Lexmark Integration Positioned to Drive Significant Profit Growth. The acquisition of Lexmark expands Xerox’s global scale and is expected to generate at least $350 million in gross cost synergies by the end of 2027. In our view, it provides a clear path toward ameaningful improvement in operating leverage and competitive positioning.
Noble Capital Markets Research Report Monday, August 17, 2026
Companies contained in today’s report:
ACCO Brands (ACCO)/OUTPERFORM – Further Expansion into Accessories Cadrenal Therapeutics (CVKD)/OUTPERFORM – 2Q26 Reported With Review Of New “Three Pillars” Strategy DLH Holdings (DLHC)/OUTPERFORM – More Contract Movement Euroseas (ESEA)/OUTPERFORM – Second Quarter 2026 Review and Outlook Star Equity Holdings, Inc. (STRR)/OUTPERFORM – Second Quarter Results And An Acquisition Xcel Brands (XELB)/OUTPERFORM – Commercialization Advances: Building Toward a Second-Half Revenue Inflection
ACCO Brands (ACCO/$4.34 | Price Target: $9) Joe Gomes [email protected] | 561-999-2262 Further Expansion into Accessories Rating: OUTPERFORM
Trust Acquisition. On Friday, ACCO announced it has entered into a definitive agreement to acquire Trust, a European provider of computer and gaming accessories. The transaction is valued at approximately $57 million. The transaction will be financed through borrowings under ACCO’s revolving credit facility, with limited impact on pro forma leverage. The transaction is expected to close in late third quarter or early fourth quarter.
Who is Trust? Founded in 1983 and headquartered in the Netherlands, Trust is a well-recognized consumer electronics brand with more than 40 years of presence in PC accessories, gaming, smart home, and mobile accessories. The company offers a comprehensive product portfolio spanning keyboards, mice, headsets, speakers, webcams, chargers, and gaming peripherals, sold through a broad network of leading retailers, e-commerce platforms, and B2B channels. Trust operates an asset-light model with outsourced manufacturing and scalable sourcing and serves customers in Europe and Latin America.
Cadrenal Therapeutics (CVKD/$1.86 | Price Target: $12) Robert LeBoyer [email protected] | (212) 896-4625 2Q26 Reported With Review Of New “Three Pillars” Strategy Rating: OUTPERFORM
2Q26 Reported With Review Of New Strategy and Product Data. Cadrenal reported a 2Q26 loss of $3.3 million, or $(1.14) per share. The company modified its strategy and plans to develop its products through collaborations, out-licensing agreements, and non-dilutive grants to conserve capital resources. On June 30, 2026, cash and cash equivalents were $4.2 million, excluding proceeds from the private placement completed July 1. The private placement raised about $3.0 million, with warrants that could raise another $5.8 million upon exercise.
The Pipeline Has Been Reorganized Into “Three Pillars”. The company has divided the pipeline into products for Cardiac Acute Critical Care, Orphan Diseases, and Post-Operative Care. These divisions emphasize how the products can address important needs before and after cardiac surgery, as well as for patient populations with few options.
DLH Holdings (DLHC/$4.66 | Price Target: $7) Joe Gomes [email protected] | 561-999-2262 More Contract Movement Rating: OUTPERFORM
New ID/IQ. According to the Department of War’s daily contract award notifications, DLH has been named to the Naval Information Warfare Center Pacific’s recent ID/IQ to provide operational exercise design and construction, operations and requirements analysis, concept formulation and development, feasibility demonstrations, and operational and technical support. This includes efforts to analyze and engineer operational, functional, and system requirements to establish national, theater, and force-level architecture. Additional efforts will include requirements verification and validation, engineering analysis, technical documentation, software and hardware design and implementation, as well as systems integration, test and evaluation, and demonstration. This is the second major ID/IQ to which DLH has been named recently.
Details. The contracting vehicle is a $278 million indefinite-delivery/indefinite-quantity, multiple-award contract with cost-plus-fixed-fee and cost-no-fee pricing. This seven-year contract includes one two-year option which, if exercised, would bring the potential value of this contract to $400 million. The period of performance is Aug. 12, 2026, through Aug. 12, 2031. DLH will have the opportunity to compete for task orders during the ordering period.
Euroseas (ESEA/$73.8 | Price Target: $92) Mark Reichman [email protected] | (561) 999-2272 Second Quarter 2026 Review and Outlook Rating: OUTPERFORM
Second Quarter Financial Results. Euroseas Ltd. reported solid second quarter 2026 financial performance supported by elevated charter rates, high fleet utilization, and disciplined cost management. While net revenues declined modestly to $56.5 million compared to $57.2 million in the prior year period due to a smaller average fleet size, adj. EBITDA increased to $40.1 million compared to $39.3 million during the second quarter of 2025, and adj. earnings per share increased to $4.70 from $4.20. We had projected net revenue of $56.5 million and adj. EBITDA of $40.1 million.
Outlook Remains Constructive. In our view, the near-term outlook remains positive, supported by strong charter rates, tight vessel availability in the feeder and intermediate segments of the containership market, and significant charter coverage through 2027. While market conditions could moderate as the supply of vessels increases and Red Sea routes potentially normalize, we think the feeder and intermediate segments are relatively well positioned versus larger vessel classes. Euroseas’ strong charter coverage of 96.0% in 2026, 81.3% in 2027, and 46.8% in 2028 is expected to insulate the company from any volatility in the market.
Star Equity Holdings, Inc. (STRR/$9.8 | Price Target: $16) Joe Gomes [email protected] | 561-999-2262 Second Quarter Results And An Acquisition Rating: OUTPERFORM
Overview. In the second quarter, Business Services delivered modest revenue growth, with gross profit down slightly year-over-year, while Energy Services posted strong year-over-year gains in revenue, gross profit, and adjusted EBITDA, reflecting activity increases and new client wins in the geothermal and mining industries. Building Solutions remained below management expectations due to market softness and contract timing.
2Q26 Results. Second quarter 2026 revenue was $54.9 million versus a pro forma $59.2 million in 2Q25. We were at $64 million. The delta was in Building Solutions, which continues to operate in a challenging environment. Adjusted EBITDA was $2.2 million versus a pro forma $8.5 million, which included a $5.5 million gain. Star reported an adjusted loss of $0.15/sh in 2Q26 compared to EPS of $0.20/sh in 2Q25.
Xcel Brands (XELB/$0.94 | Price Target: $5) Michael Kupinski [email protected] | (561) 994-5734 George Proost [email protected] | Commercialization Advances: Building Toward a Second-Half Revenue Inflection Rating: OUTPERFORM
Q2 results were softer than expected, largely due to timing. Revenue was approximately $1.1 million, compared with $1.3 million in the prior-year period, reflecting the Judith Ripka divestiture and delays associated with QVC’s bankruptcy and vendor-credit issues. Importantly, the QVC-related disruptions appear to have largely been resolved.
Commercialization remains the key story as the creator portfolio moves into the market. With the portfolio’s social media reach having expanded from roughly 5 million to more than 46 million followers, we believe the company has assembled a compelling audience from which to build consumer brands. The next several quarters should provide evidence regarding Xcel’s ability to convert that audience into sustainable royalty revenue.
Noble Capital Markets Research Report Friday, August 14, 2026
Companies contained in today’s report:
Eledon Pharmaceuticals (ELDN)/OUTPERFORM – 2Q26 Reported With Several Tegoprubart Trial Updates InPlay Oil (IPOOF)/OUTPERFORM – Second Quarter 2026 Review and Outlook Newsmax (NMAX)/OUTPERFORM – A Milestone Quarter for Growth and Profitability Saga Communications (SGA)/MARKET PERFORM – Investment Spending Weighs On Margins Sky Harbour Group (SKYH)/OUTPERFORM – Solid Second Quarter Results SKYX Platforms (SKYX)/OUTPERFORM – Another Quarter of Growth Xcel Brands (XELB)/OUTPERFORM – Creator-Commerce Strategy Advances Despite Slower Revenue Ramp
Eledon Pharmaceuticals (ELDN/$3.7 | Price Target: $10) Robert LeBoyer [email protected] | (212) 896-4625 2Q26 Reported With Several Tegoprubart Trial Updates Rating: OUTPERFORM
2Q Financial Results Were Within Expectations. Eledon reported a 2Q26 loss of $31.6 million or $(0.27) per share. The Operating Loss of $22.9 million was close to our estimate of $22.4 million, before a charge of $9.6 million for Changes In The Fair Value of Warrant Liabilities. The Net Loss excluding the non-cash charge would have been $22 million. Cash balance on June 30, 2026 was $ $88.8 million.
Preparations For A Global Phase 3 Trial In Kidney Transplantation Continue. During 2Q26, an End-Of-Phase 2 meeting was held with the FDA to discuss the Phase 3 trial design and requirements for a BLA submission. The Phase 3 trial has been designed to test tegoprubart against tacrolimus to prevent kidney transplant rejection. It is scheduled to begin in late 2026 with a target enrollment of about 600 patients. The Primary Endpoint will be non-inferiority based on a composite of BPAR (biopsy-proven acute rejection), graft loss, and death.
InPlay Oil (IPOOF/$11.89 | Price Target: $22) Mark Reichman [email protected] | (561) 999-2272 Second Quarter 2026 Review and Outlook Rating: OUTPERFORM
Second quarter financial results. Duringthe second quarter of 2026, InPlay production averaged 18,663 barrels of oil equivalents per day (boe/d), compared with 20,401 boe/d in the prior-year quarter. Despite lower production, stronger commodity pricing drove oil and natural gas sales to C$124.1 million, up 35% from C$91.6 million during the second quarter of 2025. Adjusted funds flow increased 11% to C$44.7 million from $40.1 million, while adjusted funds flow per basic share increased 8% to C$1.61 from C$1.49.
Outlook for the remainder of 2026. Supported by stronger oil prices and the expected impact of its recently announced acquisition, InPlay’s 2026 guidance forecasts average annual production of 18,900 to 19,400 boe/d, with approximately 61% to 63% light oil and natural gas liquids (NGLs), and adjusted funds flow of C$161 million to C$169 million, or approximately C$165 million at the midpoint.
Newsmax (NMAX/$9.49 | Price Target: $17) Michael Kupinski [email protected] | (561) 994-5734 A Milestone Quarter for Growth and Profitability Rating: OUTPERFORM
A milestone quarter. Newsmax reported record Q2 revenue of $54.1 million, up 16.5%, while Adjusted EBITDA improved to $5.7 million from a loss of $3.8 million, and the company generated its first quarterly net income as a public company. We believe the results provide an important early indication of the operating leverage inherent in the business model.
Higher-margin revenue streams gaining momentum. Affiliate fee revenue increased 81.9% to $13.4 million, while licensing revenue increased 563.5% to $4.6 million. In our view, continued affiliate repricing and licensing growth should improve the company’s revenue mix and provide an increasingly important driver of margin expansion.
Saga Communications (SGA/$9.71) Michael Kupinski [email protected] | (561) 994-5734 George Proost [email protected] | Investment Spending Weighs On Margins Rating: MARKET PERFORM
Q2 exceeded expectations. Revenue declined 6.5% year over year to $26.4 million, beating our estimate of $25.5 million by 3.5%. Additionally, adj. EBITDA of approximately $1.1 million compared favorably with our $0.1 million estimate. The beat reflected growth in blended digital revenue, which cushioned double-digit declines across the traditional broadcast business.
Digital continues to scale. Blended digital offering grew 60.8% during the quarter and was up 76.4% for the first 6 months of the year. Digital reached 19% of gross revenue in the first half compared with 14% a year ago. Management has brought search capabilities in-house with three dedicated specialists, hired and trained ten digital campaign managers, and migrated digital fulfillment to a new platform. In our view, the pace of blended digital growth is the most encouraging development in the quarter and the clearest evidence that the multi-year platform build is beginning to convert.
Sky Harbour Group (SKYH/$11 | Price Target: $23) Joe Gomes [email protected] | 561-999-2262 Solid Second Quarter Results Rating: OUTPERFORM
Overview. During the second quarter, the pace of investment and new construction at Sky Harbour continued to accelerate. Assets under construction and completed construction reached over $393 million, a $65 million increase year-to-date and the highest in six months in corporate history.
2Q26 Results. Sky Harbour 2Q26 revenue of $9.86 million rose nearly 50% y-o-y, driven by new campus openings in the past year and increases in occupancy and rental rates. Adjusted EBITDA improved to approximately negative $0.9 million in the second quarter of 2026 from a loss of $3.0 million in the second quarter of 2025. The Company reported a net loss of $1.2 million, or $0.04/sh, versus net income of $17.5 million, or $0.18/sh, in 2Q25, which was positively impacted by $21.8 million of unrealized gain on warrants.
SKYX Platforms (SKYX/$1.1 | Price Target: $5) Joe Gomes [email protected] | 561-999-2262 Another Quarter of Growth Rating: OUTPERFORM
Overview. SKYX Platforms just completed its 10th consecutive quarter of year-over-year growth. The Company is trending positively, generating record second quarter 2026 revenues. The Company’s builder and hotel segments are continuing to grow. With savings of up to 90% of time for installation or renovation, and up to 90% of the cost of renovation and installations, we believe SKYX’s value proposition is very strong in the hotels and builders segments. We believe the positive trends will continue to accelerate through the balance of 2026 as the Company continues to build out and execute on its channel strategy.
2Q26 Results. Revenue in 2Q26 rose 9.6% y-o-y to $25.27 million and was above our $24 million projection, with the increase due to an expansion of sales of SKYX products. The Company reported an adjusted EBITDA loss of $3.5 million, up slightly from last year’s $2.6 million loss. Net loss totaled $8.48 million, or $0.06/sh, versus a $9.1 million net loss, or $0.08/sh, in 2Q25.
Q2 results reflect a slower-than-anticipated revenue ramp, but underlying operating trends improved. Second quarter revenue of $1.1 million was below our $1.8 million estimate, largely reflecting the timing of the company’s creator-led brand commercialization and the divestiture of Judith Ripka. Importantly, adjusted EBITDA improved sequentially to a loss of $479,000 from roughly $700,000 in Q1, representing a 32% improvement, as illustrated in Figure #1 Q2 Results.
Creator-led brands begin to contribute; commercialization remains the key catalyst. Management attributed the improved adjusted EBITDA performance in part to product launches from two of its new influencer-led brands. We believe Xcel is transitioning from the investment and incubation phase of its transformation toward commercialization, with Jenny Martinez, Gemma Stafford, Cesar Millan, Coco Rocha, Christie Brinkley, and Longaberger providing multiple opportunities to expand product categories and distribution.
Noble Capital Markets Research Report Thursday, August 13, 2026
Companies contained in today’s report:
Beasley Broadcast Group (BBGI)/OUTPERFORM – Q2 EBITDA Beat Validates Re-Margin Strategy Unicycive Therapeutics (UNCY)/OUTPERFORM – 2Q26 Reported As OLC Moving Forward With FDA Manufacturing Inspection
Beasley Broadcast Group (BBGI/$21.73 | Price Target: $31) Michael Kupinski [email protected] | (561) 994-5734 George Proost [email protected] | Q2 EBITDA Beat Validates Re-Margin Strategy Rating: OUTPERFORM
Q2 results highlight meaningful operating leverage. Second-quarter revenue was $44.1 million, while Adjusted EBITDA of $5.3 million was well above our previous $2.2 million estimate. We believe the results provide encouraging evidence that recent cost actions are materially improving EBITDA conversion despite continued pressure on traditional advertising.
Cost reductions are beginning to reshape the earnings profile. Operating expenses declined 13.2% year-over-year, and management implemented an additional $10 million of annualized expense reductions during the quarter, bringing total savings over the trailing twelve months to roughly $30 million. In our view, the magnitude of these savings suggests normalized earnings power could be greater than previously anticipated.
Unicycive Therapeutics (UNCY/$5.39 | Price Target: $50) Robert LeBoyer [email protected] | (212) 896-4625 2Q26 Reported As OLC Moving Forward With FDA Manufacturing Inspection Rating: OUTPERFORM
OLC Is Moving Forward. Unicycive reported a 2Q26 loss of $1.7 million, or $(0.06) per share. The Operating Loss of $10.1 million was offset by $8.0 million in Change In Fair Value Of Warrant Liabilities, leading to a Net Loss To Common Shareholders of $1.7 million. Importantly, the FDA has given written notice of facility inspection to one of the OLC third-party manufacturers. Assuming the inspection results are positive, Unicycive will be able to resubmit its NDA for OLC. Cash and equivalents on June 30, 2026, were $61.4 million.
The Third-Party Inspection Could Complete The Missing Part Of The NDA. In June 2026, Unicycive received a CRL (Complete Response Letter) to its NDA for OLC. The stated reason was that the required FDA inspection of one of its third-party manufacturing vendors had not been performed. The notification of an inspection is good news that could allow the NDA to be resubmitted.
Noble Capital Markets Research Report Wednesday, August 12, 2026
Companies contained in today’s report:
Conduent (CNDT)/OUTPERFORM – Positioned for a Stronger Second Half Nutriband (NTRB)/OUTPERFORM – Looking Forward To Product Milestones In The Second Half FY2026 Snail (SNAL)/OUTPERFORM – Setting the Stage for a Stronger Second Half Summit Midstream Corp (SMC)/OUTPERFORM – Second Quarter Results Exceed Expectations
Conduent (CNDT/$1.58 | Price Target: $5) Michael Kupinski [email protected] | (561) 994-5734 George Proost [email protected] | Positioned for a Stronger Second Half Rating: OUTPERFORM
Q2 results reflect ongoing transformation. Continuing operations revenue declined 11.9% to $531 million, while adjusted EBITDA was $16 million, or a 3.0% margin. Commercial remained pressured by contract losses and lower volumes, while Government results reflected the timing of Medicaid implementation activity.
Guidance supports a stronger second half. Management established 2026 continuing operations guidance of $2.15-$2.25 billion of revenue and $140-$170 million of adjusted EBITDA, implying a roughly 7% EBITDA margin at the midpoint. Our estimates of $2.21 billion and $157 million, respectively, are modestly above the midpoint of guidance.
Nutriband (NTRB/$3.18 | Price Target: $15) Robert LeBoyer [email protected] | (212) 896-4625 Looking Forward To Product Milestones In The Second Half FY2026 Rating: OUTPERFORM
AVERSA Fentanyl Continues To Make Progress. Nutriband has been working in several areas to advance AVERSA Fentanyl toward the market. These include preparations for the registration trial, manufacturing, and commercialization. We continue to see AVERSA Fentanyl as an important product that could make fentanyl a safe, abuse-resistant option for pain relief.
Clinical Trial Expected Later In FY2026. The AVERSA Fentanyl application for FDA approval requires only a single clinical trial providing data to show that Fentanyl abusers prefer generic patches to the abuse-deterrent AVERSA technology. We expect this to be a short trial with a relatively small number of patients. Manufacturing clinical supplies is progressing, with the trial expected to begin around late Fall 2026.
Snail (SNAL/$4.49 | Price Target: $17.5) Michael Kupinski [email protected] | (561) 994-5734 George Proost [email protected] | Setting the Stage for a Stronger Second Half Rating: OUTPERFORM
Q2 Results Were Soft, Ahead of a Busier Second Half. Second quarter revenue declined to $19.7 million from $22.2 million, while bookings decreased to $21.8 million from $27.1 million, and EBITDA was a $3.0 million loss versus a $2.4 million loss in the prior-year period. Despite the softer quarter, first-half revenue increased 11.1% to $47.0 million, while EBITDA improved to a loss of $0.6 million from a loss of $5.8 million.
Second-Half Setup Improves Following Major ARK Content Releases. Shortly after quarter-end, Snail released Tides of Fortune, Genesis Part 1 Ascended, and Dragontopia, establishing a more active content cadence for the remainder of 2026. Management believes the broader ARK slate through 2027 provides a strong foundation for improved monetization and revenue visibility.
Second Quarter FY 2026 Financial Results. Summit Midstream generated $155.0 million of revenue, up 10.6% from the prior year quarter, and reported net income attributable to Summit Midstream Corp. of $1.6 million, or $0.11 per share, compared with a net loss of $8.0 million, or $(0.66) per share, during the prior year period. Adj. EBITDA amounted to $60.7 million compared to $61.1 million during the prior year period, as stronger Rockies and Permian performance was offset by weaker Mid-Con and Piceance segment results. We had forecast revenue of $144.4 million and adj. EBITDA of $59.7 million. Distributable cash flow increased to $36.8 million from $32.4 million, and free cash flow increased modestly to $9.4 million compared to $9.2 million during the second quarter of 2025. Sequentially, SMC’s second quarter results demonstrated meaningful improvement, supported by stronger producer activity and higher throughput across much of the portfolio.
Guidance Narrowed. Management narrowed its FY 2026 guidance range for adj. EBITDA to $235 million to $255 million from $225 million to $265 million, and increased capital expenditure guidance to $100 million to $120 million from $85 million to $105 million. The increased capital budget is primarily tied to approximately 30 additional Williston Basin well connections and incremental investment in the Double E pipeline, while accelerating producer activity, additional firm transportation agreements, and a potential Double E compression expansion support the longer-term growth outlook.
Noble Capital Markets Research Report Tuesday, August 11, 2026
Companies contained in today’s report:
Conduent (CNDT)/OUTPERFORM – Execution Takes Center Stage CoreCivic, Inc. (CXW)/OUTPERFORM – $500 Million Accelerated Share Repurchase NanoViricides (NNVC)/OUTPERFORM – NanoViricides Receives Regulatory Approval To Begin Phase 2 For Ebola In Africa NeuroSense Therapeutics Ltd. (NRSN)/OUTPERFORM – NeuroSense Announces Target Date For Canadian PrimeC Approval Application Summit Midstream Corp (SMC)/OUTPERFORM – Improving Growth Outlook and Operational Momentum The Beachbody Company (BODI)/OUTPERFORM – Finding Its Footing in Retail
Conduent (CNDT/$1.56 | Price Target: $5) Michael Kupinski [email protected] | (561) 994-5734 George Proost [email protected] | Execution Takes Center Stage Rating: OUTPERFORM
Execution continues to improve. Management reiterated that second quarter results were in line with expectations while highlighting meaningful progress across its five strategic priorities, including cost reduction, financial discipline, portfolio optimization, and pipeline conversion. Six months into the transformation, management believes the company is beginning to see tangible operational improvements.
Transportation exit strengthens the financial profile. The announced sales of the Transit and Tolling businesses are expected to generate approximately $234 million of gross proceeds, reduce off-balance-sheet obligations by roughly 80%, lower capital requirements, and provide significant flexibility to reduce debt while sharpening management’s focus on its core businesses.
CoreCivic, Inc. (CXW/$33 | Price Target: $42) Joe Gomes [email protected] | 561-999-2262 $500 Million Accelerated Share Repurchase Rating: OUTPERFORM
ASR. CoreCivic has decided how to use a portion of the proceeds from the facilities sale, and it’s a $500 million Accelerated Share Repurchase program. The Company already used over $600 million of net proceeds to reduce debt, and increased share repurchases were a logical use of additional funds, in our opinion. Upon completion of the ASR Agreement, the Company anticipates that approximately $255.8 million of share repurchase authorization will remain available.
Details. The Company made a payment of $500 million to a financial institution on August 10, 2026, and expects to receive an initial delivery of approximately 12.4 million shares of CXW common stock (about 12.5% of the outstanding) from the financial institution, pursuant to the ASR Agreement. Based on Friday’s closing price, the initial 12.4 million shares would have used approximately $400 million of the $500 million.
NanoViricides (NNVC/$1.4 | Price Target: $6) Robert LeBoyer [email protected] | (212) 896-4625 NanoViricides Receives Regulatory Approval To Begin Phase 2 For Ebola In Africa Rating: OUTPERFORM
Regulatory Approval Allows the Phase 2 Trial for NV-387 To Begin. NanoViricides has received approval to proceed with its Phase 2 trial of NV-387 for the treatment of Ebola in the Democratic Republic of Congo (DRC). We expect the Ebola trial to be followed by a separate Phase 2 trial in Mpox, also to be conducted in the DRC. This is consistent with our expected time frame for the trials.
Previous Preparations Should Allow Treatment To Start Soon. NanoViricides has completed delivery of clinical supplies of NV-387 oral solid formulation (gummies) for treatment of the trial. The trial will be conducted by OM Sai Clinical Research, a contract research organization (CRO) based in India. The CRO has assembled a clinical team with a Principal Investigator, local clinicians, and a university in the region to support the trial. The approval by ACOREP (Autorité Congolaise de Réglementation Pharmaceutique, the Congolese Pharmaceutical Regulatory Authority) should allow the trial to start patient treatment shortly.
NeuroSense Therapeutics Ltd. (NRSN/$0.48 | Price Target: $9) Robert LeBoyer [email protected] | (212) 896-4625 NeuroSense Announces Target Date For Canadian PrimeC Approval Application Rating: OUTPERFORM
Pre-Application Process Has Been Completed. NeuroSense announced that it has completed Pre-NDS meetings with Health Canada and plans to submit a New Drug Submission (NDS) for PrimeC in its ALS indication. These meetings focused on whether the data could support approval and the submission requirements. The target date is December 2026. We see this as good news that is consistent with our expectations.
We View The Canadian NDS Process As An Important Milestone For PrimeC. The NDS application will include the Phase 2b PARADIGM trial data, with additional preclinical and supporting data. The primary endpoint in the trial showed a reduction in TDP-43 (TAR DNA-binding Protein 43, a protein that drives ALS progression and deterioration). The data also showed increased median survival, improved functional assessments, biomarkers showing slower disease progression, as well as safety and tolerability. Approval would be based on Health Canada’s analysis of these data.
Summit Midstream Corp (SMC/$31.84 | Price Target: $49) Mark Reichman [email protected] | (561) 999-2272 Improving Growth Outlook and Operational Momentum Rating: OUTPERFORM
Second Quarter FY 2026 Financial Results. Summit Midstream generated $155.0 million of revenue, up 10.6% from the prior-year quarter, and reported net income attributable to Summit Midstream Corp. of $1.6 million, or $0.11 per share, compared with a net loss of $8.0 million, or $(0.66) per share, during the prior year period. Adj. EBITDA amounted to $60.7 million compared to $61.1 million during the prior year period, as stronger Rockies and Permian performance was offset by weaker Mid-Con and Piceance segment results. We had forecast revenue of $144.4 million and adj. EBITDA of $59.7 million. Distributable cash flow increased to $36.8 million from $32.4 million, and free cash flow increased modestly to $9.4 million compared to $9.2 million during the second quarter of 2025. Sequentially, SMC’s second quarter results demonstrated meaningful improvement, supported by stronger producer activity and higher throughput volume across much of the portfolio.
Guidance Narrowed. Management narrowed its FY 2026 guidance range for adj. EBITDA to $235 million to $255 million from $225 million to $265 million, and increased capital expenditure guidance to $100 million to $120 million from $85 million to $105 million. The increased capital budget is primarily tied to approximately 30 additional Williston Basin well connections and incremental investment in the Double E pipeline, while accelerating producer activity, additional firm transportation agreements, and a potential Double E compression expansion support the longer-term growth outlook.
The Beachbody Company (BODI/$10.22 | Price Target: $22) Michael Kupinski [email protected] | (561) 994-5734 Jacob Mutchler [email protected] | Finding Its Footing in Retail Rating: OUTPERFORM
Another profitable quarter. Q2 revenue of $49.6 million exceeded the midpoint of guidance, while adjusted EBITDA of $6.7 million exceeded the high end and marked the company’s 11th consecutive quarter of positive adjusted EBITDA. While revenues were in line, the company exceeded our $4.5 million adj. EBITDA estimate.
Retail traction encouraging. Shakeology distribution expanded to 131 Sprouts stores, with early reorders supporting favorable sell-through, while the company recently launched in 481 Vitamin Shoppe locations. Approximately 12 additional retail decisions are expected between mid-September and late November.
Overview. As we highlighted in our First Look at CoreCivic’s operating results, the Company’s second quarter 2026 financial results exceeded management expectations, driven by lower operating costs and slightly higher populations from ICE. While the quarterly operating results were a positive in and of themselves, the major news came post-quarter’s end with the announcements of sales of four detention facilities to the Federal government for total gross proceeds of $2.2 billion and a net of approximately $1.6 billion. The Company remains in discussions with ICE for the potential sale of additional facilities, as well as for new contracts at existing and/or idle facilities.
Capital. With the facilities sold, the current capital structure has significantly changed. Net proceeds, after taxes and sale costs, were approximately $1.6 billion. The Company used $608.5 million to pay down debt, including $238.5 million of the 4.75% unsecured notes that will be repaid on August 12th. After income taxes and debt repayments, the Company will have approximately $1 billion of cash on hand, total debt outstanding of $739.1 million, and $553.3 million of borrowing capacity under the revolving credit facility.
E.W. Scripps (SSP/$3.32 | Price Target: $10) Michael Kupinski [email protected] | (561) 994-5734 George Proost [email protected] | Transformation and Regulatory Change Create Long-Term Upside Rating: OUTPERFORM
Mixed Q2 results, but EBITDA outlook remains intact. Second-quarter results reflected continued pressure in the Scripps Networks business from weak national advertising, retransmission disruptions, and Nielsen measurement changes. However, stronger political advertising guidance and accelerated transformation savings largely offset these headwinds, leading us to maintain our 2026 adjusted EBITDA estimate despite modest revenue revisions.
Transformation plan gains momentum. Management increased its expected year-end transformation run-rate savings to $100 million, up from $75 million previously, reinforcing confidence in its target of delivering $125–150 million of incremental annualized EBITDA by 2028 through AI, automation, and operational modernization.
First Phosphate Corp. (FRSPF/$1.29 | Price Target: $2) Mark Reichman [email protected] | (561) 999-2272 Nasdaq Uplisting Enhances and Expands Investor Access Rating: OUTPERFORM
Nasdaq Listing. First Phosphate’s American Depositary Receipts (ADRs) will uplist to the Nasdaq Global Market under the ticker PHOS, effective August 10, 2026. The ADR ratio remains 10 common shares per ADR, and existing Level 1 ADRs will be delisted from the OTCQX and automatically converted to Level 2 ADRs for Nasdaq trading. First Phosphate’s currently listed common shares on the OTCQX, CSE, and Frankfurt Stock Exchange are unaffected. Uplisting to Nasdaq is expected to enhance U.S. market access for First Phosphate, which is developing a vertically integrated North American supply chain for LFP battery materials used for energy storage, data centers, robotics, mobility, and national security applications.
No New Capital. First Phosphate is the second self-sponsored ADR to uplist to Nasdaq and the first to do so without a concurrent capital raise. The Nasdaq uplisting does not involve issuing additional shares or raising new capital. Investors may continue converting First Phosphate common shares into ADRs at no cost through The Bank of New York Mellon, the depositary bank for the First Phosphate ADR program, until December 31, 2026. First Phosphate is well funded with more than C$30 million in treasury and access to C$21.5 million in Canadian government contributions, providing funding through a final investment decision (FID).
Graham (GHM/$111.68) Joe Gomes [email protected] | 561-999-2262 Strong Start to Fiscal 2027 Rating: MARKET PERFORM
Overview. Graham’s first quarter results reflect continued disciplined execution. The Company experienced revenue growth across all business units, reflecting the strength of Graham’s diversified business model and strong demand for the Company’s mission-critical technologies. Bookings remained strong, and backlog was at a record level.
1Q27 Results. First quarter fiscal 2027 net sales were $71.3 million, up $15.9 million, or 29%. We had projected $66 million. 1Q27 adjusted EBITDA increased 28% to $8.8 million, representing an adjusted EBITDA margin of 12.3%, which was consistent with the prior year period. We were at $8.3 million and 12.7%. Graham reported 1Q27 adjusted net income of $5.7 million, or $0.49/sh, compared with $4.9 million and $0.45/sh last year. This exceeded our $5.1 million and $0.43/sh estimate.
The Cullgen Acquisition Highlights 2Q26. Gyre reported a 2Q26 loss of $14.3 million, or $(0.12) per share. Revenues of $29.1 million compared with $22.5 million in 1Q26, consistent with our estimates. We have expected a transition year between Etuary market maturity and the expected hydronidone launch, supplemented by the Cullgen acquisition. Revenue guidance for FY2026 was reiterated at $100.5 to $111.0 million. Cash and equivalents on June 30, 2026 were $103.2 million.
Hydronidone NDA Accepted For Review. In May 2026, the New Drug Application (NDA) for hydronidone (previously F351) was accepted for review by the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA). This followed the Priority Review status granted by the NMPA in March.
Kelly Services (KELYA/$15.19 | Price Target: $19) Joe Gomes [email protected] | 561-999-2262 Improving Momentum Rating: OUTPERFORM
Overview. In the second quarter of 2026, Kelly exceeded guidance for both revenue and adjusted EBITDA margin, driven by growing momentum from the Company’s growth and efficiency initiatives as well as constructive demand trends in parts of the portfolio. Notably, Kelly delivered sequential improvements in each of the business segments.
2Q26 Results. Revenue was $1.04 billion, down approximately 5.8% y-o-y, but significantly better than the expected 7-9% revenue decline. We were at $1.01 billion. Adjusted EBITDA for 2Q26 was $16.1 million, a 3.0% margin, above management’s 2.5% projection. We were at $25 million and 2.5%. Adjusted EPS was $0.37 versus $0.54 in 2Q25. We had estimated $0.30.
NN (NNBR/$3.77 | Price Target: $6) Joe Gomes [email protected] | 561-999-2262 A New Era Rating: OUTPERFORM
A New Era. NN delivered strong financial performance in the second quarter with record results in many areas. These new sales are higher margin, attached to higher growth rate end markets, and mostly immediate 2026 startup. The Company is achieving many multi-year goals and revising outlooks-including raising full-year guidance- based upon actual results. And, significantly, post-quarter-end management implemented what can only be described as a game-changing restructuring of the capital structure.
Growth. During the quarter, NN secured significant 2026 immediate-supply awards for Data Center liquid cooling products, robotic surgery medical products, and defense products. New business wins through July totaled $80 million. Management increased the full-year new business win goal from $80 million to the $100 million range.
The GEO Group (GEO/$30.69 | Price Target: $40) Joe Gomes [email protected] | 561-999-2262 Strong 2Q; Raising Price Target Rating: OUTPERFORM
Overview. GEO delivered better-than-expected performance in the second quarter of 2026, reflecting significant revenue growth from the contracts that the Company entered into throughout 2025. With recently signed new contracts and still significant idle capacity, we believe there remains substantial opportunity for additional increases in operating results.
2Q26 Results. Second quarter 2026 revenue was $732.1 million, up 15% y-o-y, and exceeding our $720 million projection. Adjusted EBITDA was up 20% to $142 million, or a 19.4% margin, and above our $129.3 million estimate. GEO reported 2Q26 net income attributable to GEO Operations of $47.5 million, or $0.36/sh, and $29.1 million, or $0.21/sh, in 2Q25. Adjusted EPS was $0.37/sh, compared to $0.22/sh in 2Q25. We were at $0.28/sh for both.
Noble Capital Markets Research Report Friday, August 7, 2026
Companies contained in today’s report:
E.W. Scripps (SSP)/OUTPERFORM – Execution Becomes the Investment Story EuroDry (EDRY)/OUTPERFORM – Second Quarter 2026 Review and Outlook Information Services Group (III)/OUTPERFORM – Post Call Commentary Kratos Defense & Security (KTOS)/OUTPERFORM – That Didn’t Take Long Kuya Silver (KUYAF)/OUTPERFORM – Multiple Value Drivers Emerging Ocugen (OCGN)/OUTPERFORM – Q2 2026 Reported With Three Late-Stage Trials Advancing With A Stronger Balance Sheet Resolution Minerals Ltd (RLMLF)/OUTPERFORM – Update for the Quarter Ended June 30, 2026 Townsquare Media (TSQ)/OUTPERFORM – Digital Momentum Accelerates
E.W. Scripps (SSP/$2.95 | Price Target: $10) Michael Kupinski [email protected] | (561) 994-5734 Jacob Mutchler [email protected] | Execution Becomes the Investment Story Rating: OUTPERFORM
Q2 results fell short of expectations, reflecting both cyclical and structural pressures. Revenue declined 9.2% year over year, as retransmission blackouts with Comcast and DirecTV reduced distribution revenue by approximately $26.7 million, while continued weakness in national advertising and audience measurement challenges weighed on the Networks business.
Transformation efforts are accelerating and should improve earnings power over time. Management now expects to achieve approximately $100 million in annualized run-rate cost savings by year-end as part of its broader plan to deliver $125–150 million of incremental enterprise EBITDA by 2028 through AI, automation, and operational efficiencies.
EuroDry (EDRY/$29.82 | Price Target: $47) Mark Reichman [email protected] | (561) 999-2272 Second Quarter 2026 Review and Outlook Rating: OUTPERFORM
2Q 2026 Financial Results. EuroDry Ltd. reported strong 2Q 2026 financial performance compared to the prior year period, driven primarily by a favorable dry bulk market and higher time charter equivalent (TCE) rates. Total net revenues increased 57% year-over-year to $17.7 million, while average time charter equivalent rates more than doubled to $20,398 per day compared with $10,428 per day during the prior year period. Adjusted net income attributable to controlling shareholders amounted to $6.9 million, or $2.44 per diluted share, compared to a net loss of $3.0 million, or $(1.10) per diluted share, in the prior year period. Adjusted EBITDA increased to $11.7 million compared to $1.9 million during the prior year period, reflecting strong operating leverage as TCE rates increased. We had projected 2Q revenue and adj. EBITDA of $17.4 million and $9.3 million, respectively.
Strong Operational Quarter. Fleet utilization improved to 100.0% compared to 99.3% during the prior year period, with commercial utilization at 100%, reflecting minimal downtime and effective charter execution. Vessel operating expenses declined modestly to $6,608 per day compared to $6,785 per day during the prior year period, while total operating expenses decreased to $7,444 per day compared to $7,539 during the second quarter of 2025.
Information Services Group (III/$5 | Price Target: $6.5) Joe Gomes [email protected] | 561-999-2262 Post Call Commentary Rating: OUTPERFORM
Strong Quarter. ISG had a strong second quarter with both revenue and adjusted EBITDA above expectations. The second quarter marks the seventh quarter in a row that adjusted EBITDA has grown by double digits. Expanding margins reflect the continued evolution of ISG’s business toward higher-value advisory work, growth in recurring revenues, and increasing leverage from AI-enabled delivery, in our view.
AI Opportunity. AI is a tailwind for ISG. ISG is taking advantage of the need for AI, reshaping the business as an AI-centered technology research and advisory firm to drive stronger client demand and improve how services are delivered. Nearly half of ISG’s clients generated AI-related revenue during the quarter. Growth was broad-based across industries, led by consumer, health sciences, and manufacturing.
Kratos Defense & Security (KTOS/$57.41 | Price Target: $145) Joe Gomes [email protected] | 561-999-2262 That Didn’t Take Long Rating: OUTPERFORM
From Opportunity to Reality. Less than 48 hours after speaking of these potential opportunities (among a bunch of other opportunities), Kratos has been awarded a U.S. Army contract related to the Javelin Missile System, and Kratos partner Boeing announced it has been awarded a funding contract to begin supplying long-range JDAMs that incorporate Kratos turbojet engines.
JDAM. The Air Force awarded Boeing a $75 million production contract to begin supplying long-range JDAMs. The long-range variant adds a Kratos TDI-J85 turbojet providing 200 pounds of thrust to enable jets to attack from a much safer distance. The 2027 National Defense Authorization Act includes about $277 million for 1,150 upgraded JDAM guidance tail kits with M-Code GPS for the legacy munitions. Industry experts note the new version will cost far less than more exquisite stand-off munitions, so they should be considered as an affordable mass capability, playing right into Kratos’ key strengths, in our opinion.
Kuya Silver (KUYAF/$0.56 | Price Target: $2.5) Mark Reichman [email protected] | (561) 999-2272 Multiple Value Drivers Emerging Rating: OUTPERFORM
Early results are encouraging. Kuya Silver reported encouraging preliminary sampling results from historic stockpiles and tailings at its Silver Kings Project in Northern Ontario, suggesting that previously mined above-ground materials may contain significant recoverable silver and cobalt. The strongest results came from the Kerr Lake Mill crushed stockpile, which returned a master composite grade of 168 g/t silver and 0.365% cobalt (276 g/t silver equivalent), while Frontier tailings returned 75 g/t silver and 0.037% cobalt. These findings support the company’s view that modern processing technologies could unlock value from legacy mining waste.
The program targeted multiple historic sites. The sampling program evaluated seven historic sites, including tailings facilities, blast rock stockpiles, and crushed material left by previous operators. These represent attractive reprocessing targets because historical mining methods were less efficient and often left behind economically valuable mineralization. While the results are preliminary and not representative of entire stockpiles, they demonstrate the potential for recovering silver, cobalt, and, in some cases, copper using modern sorting and processing techniques.
Ocugen (OCGN/$1.24 | Price Target: $12) Robert LeBoyer [email protected] | (212) 896-4625 Q2 2026 Reported With Three Late-Stage Trials Advancing With A Stronger Balance Sheet Rating: OUTPERFORM
Ocugen Raised Cash and Prepared To Begin Phase 3. Ocugen reported a 2Q26 loss of $24.9 million, or $(0.07) per share. The Operating Loss of $16.4 million was in line with our estimate, while a Loss on Extinguishment of Debt contributed $2.4 million to the Net Loss. Importantly, the company is planning to start the Phase 3 trial for OCU410 in GA-dAMD during 3Q, consistent with our expectations. In May 2026, the company issued Convertible Notes that raised approximately $112.5 million, ending the quarter with $100.4 million in cash.
Convertible Notes Balance Cash Needs With Dilution. In May 2026, the company issued $130.0 million in 6.75% Convertible Notes, adding net cash of approximately $112.5 million. About $32.7 million of the proceeds were used to repay a 12.25% interest loan. The remaining proceeds brought cash on hand to $100.4 million. This should provide sufficient cash to fund its three products through clinical trials, regulatory approval, and product launches through FY2028.
Resolution Minerals Ltd (RLMLF/$0.03 | Price Target: $0.15) Mark Reichman [email protected] | (561) 999-2272 Update for the Quarter Ended June 30, 2026 Rating: OUTPERFORM
Making Significant Progress. Resolution Minerals has advanced the Horse Heaven Project as an integrated U.S. critical minerals platform encompassing antimony, tungsten, and gold. Antimony Ridge received FAST-41 Transparency Coverage, with Golden Gate receiving the same status after quarter-end, while Resolution was also admitted to the U.S. Defense Industrial Base Consortium. Together, these developments could accelerate permitting, enhance access to U.S. government and strategic funding channels, and reinforce the projects’ importance as a domestic critical-mineral supply source. Resolution continues to advance drilling, metallurgy, and permitting activities that support its long-term development strategy.
Project Highlights. Antimony Ridge continues to demonstrate excellent scale and grade, with more than 100 high-grade antimony veins identified and metallurgical testing producing a 99.38% antimony trioxide product. At Golden Gate, the company advanced a 13,700-meter drill program to support a maiden mineral resource estimate, while metallurgical testing returned strong gold recoveries that further de-risk future development. Post quarter-end, approximately half of the planned drilling program has been completed
Townsquare Media (TSQ/$6.33 | Price Target: $15) Michael Kupinski [email protected] | (561) 994-5734 Jacob Mutchler [email protected] | Digital Momentum Accelerates Rating: OUTPERFORM
Q2 exceeded expectations. Revenue of $115.4 million and Adjusted EBITDA of $24.8 million were within management’s guidance, while Digital Advertising accelerated to 11% year-over-year growth,driven by continued strength in programmatic advertising, owned-and-operated digital properties, and Media Partnerships.
Digital transformation gaining traction. Townsquare’s Digital First strategy continues to differentiate the company from traditional radio peers. During the first half of 2026, digital businesses generated 57% of total revenue and 59% of total segment profit, while the Media Partnerships platform expanded to 16 partners, creating a scalable, capital-light growth opportunity beyond the company’s owned markets.
Noble Capital Markets Research Report Thursday, August 6, 2026
Companies contained in today’s report:
CoreCivic, Inc. (CXW)/OUTPERFORM – First Look 2Q26 Results First Phosphate Corp. (FRSPF)/OUTPERFORM – Federal Funding for Infrastructure Planning Graham (GHM)/MARKET PERFORM – New Awards Information Services Group (III)/OUTPERFORM – First Look 2Q26 Operating Results InPlay Oil (IPOOF)/OUTPERFORM – Strategic Acquisition Enhances Outlook NN (NNBR)/OUTPERFORM – First Look 2Q26 Operating Results; Deleveraging Transaction ONE Group Hospitality (STKS)/OUTPERFORM – Implementing the Asset Light Strategy
CoreCivic, Inc. (CXW/$31.23 | Price Target: $35) Joe Gomes [email protected] | 561-999-2262 First Look 2Q26 Results Rating: OUTPERFORM
Overview. CoreCivic’s 2Q26 financial results exceeded management expectations, driven by lower operating costs and slightly higher populations from U.S. Immigration and Customs Enforcement. Recent contracts at 4 facilities added $80.1 million to revenue and $20.1 million to operating income in the quarter. These facilities continue to be in various stages of activation.
2Q26 Results. Revenue increased 27.3% y-o-y to $684.9 million and was above our $618 million projection. Adjusted EBITDA was $109.4 million, compared to $103.3 million in 2Q25 and our $108.9 million estimate. Adjusted net income was $37.7 million, or $0.38 per diluted share, in 2Q26, compared with $39.7 million and $0.36, respectively, last year. We would note 2Q25 EPS benefited from $11.6 million, or $0.08 per share, of Employee Retention Credits, along with interest thereon, available under the CARES Act. Excluding the CARES Act benefit, 2Q26 adjusted EPS would have reflected more pronounced y-o-y growth.
First Phosphate Corp. (FRSPF/$1.18 | Price Target: $2) Mark Reichman [email protected] | (561) 999-2272 Federal Funding for Infrastructure Planning Rating: OUTPERFORM
Federal Funding for Begin-Lamarche. First Phosphate Corp. has finalized agreements with the Government of Canada to receive C$4.84 million in non-repayable funding through Natural Resources Canada’s First and Last Mile Fund to support infrastructure planning for its Bégin-Lamarche phosphate deposit in Québec. The new funding builds on the C$16.7 million previously awarded by NRCan in March 2026, demonstrating continued federal support for advancing the strategic critical minerals project.
Investments in Infrastructure Planning. The funding will support two key initiatives: 1) approximately C$3.07 million for studies and design of a 161-kV power transmission line and substations, and 2) approximately C$1.77 million for planning a new mine access road and evaluating upgrades to bypass roads to support transportation between Begin-Lamarche and regional infrastructure, including rail links and the Port of Saguenay. Both projects include technical, environmental, and economic studies, engineering design, and consultation with indigenous communities and the public.
Graham (GHM/$104.47) Joe Gomes [email protected] | 561-999-2262 New Awards Rating: MARKET PERFORM
Awards. Graham Corporation was awarded two contracts for a combined value of over $43 million. These awards reflect the continued demand the Company is seeing across its defense platforms. The revenue for the contracts will be reflected in the Company’s first and second fiscal year 2027 backlog.
MK48 Mod 7 Heavyweight Torpedo. The first award is a follow-on fourth option year supporting the MK48 Mod 7 Heavyweight Torpedo program, awarded in the first quarter of fiscal 2027, which ended June 30, 2026. The Company will continue to provide alternators and regulators under this option year.
Information Services Group (III/$4.26 | Price Target: $6.5) Joe Gomes [email protected] | 561-999-2262 First Look 2Q26 Operating Results Rating: OUTPERFORM
Overview. Information Services Group had a very strong second quarter, generating the highest quarterly revenue since 2023. Growth in the quarter was led by Europe, up 10%, and the Americas, up 7%, while recurring revenues reached a new quarterly high of $30 million, driven by the Company’s AI-centered research and governance services.
2Q26 Results. Reported revenues for the second quarter were $65.5 million, up 6.4% from $61.6 million in the prior year, and above our $63 million projection. Second-quarter adjusted EBITDA was $9.4 million, up 13% y-o-y. Adjusted EBITDA margin was 14.3%, compared with 13.5% in the prior year’s second quarter. We were at $8.45 million and 13.4%, respectively. ISG reported adjusted net income for 2Q26 of $5.0 million, or $0.10 per share, compared with adjusted net income of $4.1 million, or $0.08 per share, in 2Q25. We had projected $4.4 million and $0.09/sh.
InPlay Oil (IPOOF/$10.45 | Price Target: $22) Mark Reichman [email protected] | (561) 999-2272 Strategic Acquisition Enhances Outlook Rating: OUTPERFORM
Accretive Strategic Acquisition. InPlay Oil announced the acquisition of a private oil and gas producer for C$54.25 million, adding approximately 1,400 boe/d of oil-weighted production and increasing company-wide production to more than 20,100 boe/d. The acquired assets are contiguous with InPlay’s existing operations, enabling approximately C$2.5 million of annual cost synergies, while adding 50 drilling locations and immediately enhancing adjusted funds flow and free adjusted funds flow on a per-share basis. The transaction is expected to close by the end of August, subject to customary closing conditions. Post-close, InPlay expects to have more than 450 total drilling locations, including approximately 230 Tier-1 locations.
Corporate Guidance. InPlay continues to execute strongly, with recent Cardium wells materially outperforming expectations and being drilled ahead of schedule, allowing InPlay to expand its 2026 drilling program to 17 net wells on a pro forma basis. Reflecting stronger operational performance and the acquisition, management increased 2026 guidance, including adjusted funds flow (AFF) to C$161 million to C$169 million, free adjusted funds flow (FAFF) to C$79 million to C$89 million, and FAFF yield to 19% to 21%, despite higher capital spending of C$80 million to C$82 million.
NN (NNBR/$3.9 | Price Target: $6) Joe Gomes [email protected] | 561-999-2262 First Look 2Q26 Operating Results; Deleveraging Transaction Rating: OUTPERFORM
Overview. NN delivered strong financial performance in 2Q26 with record results in many areas. The Company’s 5-pillar growth program is delivering results. New sales are higher margin, attached to higher-growth-rate end markets, and mostly immediate 2026 startup. The second half of 2026 is expected to reflect continued momentum and strong financial performance.
2Q26 Results. Net sales for 2Q26 were $128.7 million, an increase of 19.3% compared to net sales of $107.9 million for the same period in 2025. We were at $116 million. Adjusted EBITDA was $17.9 million, an increase of 36.1% compared to adjusted EBITDA of $13.2 million for 2Q25, primarily driven by improved sales mix and operating performance. We had projected $15 million. Adjusted net income was $5.5 million, or $0.11 per diluted common share, an increase of $4.7 million, or $0.09 per diluted common share, compared to adjusted net income of $0.7 million, or $0.02 per diluted common share, in 2Q25. We were at $2.2 million and $0.04, respectively.
ONE Group Hospitality (STKS/$1.78 | Price Target: $5) Joe Gomes [email protected] | 561-999-2262 Implementing the Asset Light Strategy Rating: OUTPERFORM
Overview. The ONE Group Hospitality’s second quarter 2026 results underscore the momentum the Company is building across the portfolio, driven by the continued strength of the Company’s Vibe Dining brands. Consolidated comparable sales were positive, with positive transaction growth across all segments. Quarterly margin performance was strong, with the consolidated margin expanding 110 basis points to 16.4%.
2Q26 Results. ONE Group reported 2Q26 revenue of $200.5 million, down 3.3% from $207.4 million for the same quarter last year. The decrease was primarily attributable to the closed grill concept restaurants, partially offset by an increase in comparable restaurant sales and sales from new restaurants opened since July 2025. Adjusted EBITDA attributable to ONE Group was $21.1 million in 2Q26 compared to $23.4 million in 2Q25, a decrease of 9.7%, primarily due to increased investment in marketing during the quarter and an increase in general and administrative expenses, excluding stock-based compensation.
Noble Capital Markets Research Report Wednesday, August 5, 2026
Companies contained in today’s report:
Commercial Vehicle Group (CVGI)/OUTPERFORM – Momentum Continues Building CoreCivic, Inc. (CXW)/OUTPERFORM – Opening Another Previously Idle Facility FreightCar America (RAIL)/OUTPERFORM – Second Quarter 2026 Review and Outlook InPlay Oil (IPOOF)/OUTPERFORM – Updating Estimates Based on Higher Second Quarter Crude Oil Prices Kratos Defense & Security (KTOS)/OUTPERFORM – Strong 2Q26 Top Line Growth; Momentum Continues to Build Superior Group of Companies (SGC)/OUTPERFORM – Branded Products Powers Earnings Growth
Commercial Vehicle Group (CVGI/$3.89 | Price Target: $7) Joe Gomes [email protected] | 561-999-2262 Momentum Continues Building Rating: OUTPERFORM
Overview. CVG delivered year-over-year revenue growth across all three segments, reflecting ongoing efforts to reduce end-market concentration in cyclical North American Class 8 truck exposure through geographic and end-market diversification. While there are still macroeconomic uncertainties to monitor, CVG is hitting its stride as new business wins are ramping coincidentally with a recovery in key end markets.
2Q26 Results. CVG reported 2Q26 revenue of $195.2 million, up from $172 million in the year-ago period, a 13.5% increase, driven by increased customer demand in international markets and the ramp of previously awarded new business wins across all three operating segments. We were at $173 million. Gross margin improved both y-o-y and sequentially to 12.9%. One-time items impacted the reported bottom line. On an adjusted basis, CVG reported a net loss of $0.13/sh, up from a loss of $0.09/sh last year, reflecting increased incentive comp expense in 2Q26 over 2Q25.
CoreCivic, Inc. (CXW/$30.15 | Price Target: $35) Joe Gomes [email protected] | 561-999-2262 Opening Another Previously Idle Facility Rating: OUTPERFORM
New Award. CoreCivic has been awarded a new contract with U.S. Immigration and Customs Enforcement (“ICE”) to utilize the Company’s 1,600-bed Prairie Correctional Facility located in Appleton, Minnesota, a facility that has been idle since 2010. Awards seem to be picking up once again, especially for previously idle facilities, suggesting to us that ICE is moving back to the tried-and-true detention operating model, with less focus on alternative detention models.
Impact. The new contract commences on August 11, 2026, for a term of five years. The agreement provides for a fixed monthly payment plus an incremental per diem payment based on detainee populations. Taking into account start-up activities and the phased commencement of intake operations, we currently expect an immaterial impact to earnings for the remainder of 2026. Once the facility is fully activated, management expects this facility to generate total annual revenue of approximately $75 million. The facility should begin receiving detainees in the fourth quarter of 2026, with the full ramp estimated to be complete in the second quarter of 2027.
FreightCar America (RAIL/$8.54 | Price Target: $15) Mark Reichman [email protected] | (561) 999-2272 Second Quarter 2026 Review and Outlook Rating: OUTPERFORM
Second Quarter FY 2026 Financial Results. RAIL generated a 2Q FY26 adjusted net loss to common stockholders of $821.0 thousand, or $(0.02) per share, compared to adjusted net income of $3.8 million, or $0.11 per share, during the prior year period. Gross margin as a percentage of revenue amounted to 5.5% compared to 15.0% in 2Q FY 2025. Revenue and rail car deliveries declined to $113.1 million and 927, compared to $118.6 million and 939 during the prior year period. Adj. EBITDA amounted to $1.2 million compared to $9.3 million in 2Q FY 2025.
Updated FY 2026 Guidance. Management updated its FY 2026 guidance. Railcar deliveries are expected to be in the range of 3,500 to 3,900, revenue in the range of $410 to $460 million, and adj. EBITDA in the range of $36 to $44 million. Prior guidance projected railcar deliveries in the range of 4,000 to 4,500, revenue in the range of $500 to $550 million, and adj. EBITDA in the range of $41 to $50 million.
InPlay Oil (IPOOF/$10.65 | Price Target: $20) Mark Reichman [email protected] | (561) 999-2272 Updating Estimates Based on Higher Second Quarter Crude Oil Prices Rating: OUTPERFORM
Updating estimates. We have increased our Q2 FY2026 revenue, adjusted funds flow (AFF), and AFF per share estimates to C$122.0 million, C$49.6 million, and C$1.77, respectively, from C$104.0 million, C$36.2 million, and C$1.29. While we have lowered our production estimate to 18,663 barrels of oil equivalent per day (boe/d) from 18,875 boe/d due to Q2 weather impacts, the increases in our estimates are largely due to higher crude oil prices. For FY 2026, we now project revenue, AFF, and AFF per share of C$425.6 million, C$162.5 million, and C$5.80, respectively, compared to our prior estimates of C$406.2 million, C$148.4 million, and C$5.29. Our FY 2026 average production forecast of 18,900 boe/d is unchanged.
Outlook. InPlay has approximately 190 Tier 1 drilling locations that provide an estimated 10 to 15 years of high-return inventory. The company’s low-decline asset base supports sustainable free cash flow generation while limiting capital requirements needed to maintain production. Conservative leverage provides capacity for future acquisitions while maintaining shareholder returns through the dividend.
Kratos Defense & Security (KTOS/$51.87 | Price Target: $145) Joe Gomes [email protected] | 561-999-2262 Strong 2Q26 Top Line Growth; Momentum Continues to Build Rating: OUTPERFORM
Overview. Kratos’ second quarter results reflect strong execution by the Company, in our view. The Company’s strategy, including making internally funded investments to be first-to-market with relevant hardware and software that is engineered up front for affordable mass production at scale and is aligned with the Department of War’s priorities, continues to resonate, in our view.
2Q26 Results. Revenues for the second quarter were $458.8 million, above management’s guide of $400 million-$410 million. We were at $405 million. Adjusted EBITDA for the second quarter was $38.2 million, above the high end of the estimated range of $30 million-$35 million, reflecting the increased revenue and revenue mix. We had forecast $33 million. GAAP net income for 2Q26 was $4.4 million, and GAAP EPS was $0.02, compared to $2.9 million and $0.02, respectively, for 2Q25. Adjusted EPS was $0.21 for 2Q26, compared to $0.11 for 2Q25.
Superior Group of Companies (SGC/$13.95 | Price Target: $16) Michael Kupinski [email protected] | (561) 994-5734 George Proost [email protected] | Branded Products Powers Earnings Growth Rating: OUTPERFORM
An impressive earnings beat. Q2 revenue increased 2.6% to $147.8 million, while adjusted EBITDA rose 26.6% to $7.7 million and adjusted EPS more than doubled to $0.21. The results beat our estimates of $143.8 million, $6.5 million, and $0.08 per share, respectively.
Branded Products powers the recovery. Revenue advanced 6.2%, and segment EBITDA increased 24.9% to $11.2 million, supported by a favorable customer mix, improved sourcing, and growing volumes from existing customers. Management indicated that the segment has favorable operating momentum into the second half.
Noble Capital Markets Research Report Tuesday, August 4, 2026
Companies contained in today’s report:
FreightCar America (RAIL)/OUTPERFORM – RAIL Provides Updated Outlook; Webinar at 11:00 AM ET V2X (VVX)/OUTPERFORM – Solid Second Quarter Results
FreightCar America (RAIL/$8.24 | Price Target: $15) Mark Reichman [email protected] | (561) 999-2272 RAIL Provides Updated Outlook; Webinar at 11:00 AM ET Rating: OUTPERFORM
Second Quarter FY 2026 Financial Results. RAIL generated a 2Q FY26 adjusted net loss to common stockholders of $821.0 thousand, or $(0.02) per share, compared to adjusted net income of $3.8 million, or $0.11 per share, during the prior year period. We had projected net income of $350 thousand or $0.01 per share. Gross margin as a percentage of revenue amounted to 5.5% compared to 15.0% in 2Q FY 2025. Revenue and rail car deliveries declined to $113.1 million and 927, compared to $118.6 million and 939 during the prior year period. We had forecast revenue of $112.3 million and deliveries of 923. Adj. EBITDA amounted to $1.2 million compared to $9.3 million in 2Q FY 2025 and our estimate of $5.7 million. We had projected higher gross margin.
Updated FY 2026 Guidance. Management updated its FY 2026 guidance. Railcar deliveries are expected to be in the range of 3,500 to 3,900, revenue in the range of $410 to $460 million, and adj. EBITDA in the range of $36 to $44 million. Prior guidance projected railcar deliveries in the range of 4,000 to 4,500, revenue in the range of $500 to $550 million, and adj. EBITDA in the range of $41 to $50 million. Our current estimates are at the low end of prior guidance. We will update our estimates following today’s investor call.
V2X (VVX/$86.38 | Price Target: $92) Joe Gomes [email protected] | 561-999-2262 Solid Second Quarter Results Rating: OUTPERFORM
Overview. V2X’s reported strong second quarter performance reflecting consistent strategic execution, robust demand for the Company’s differentiated capabilities, and continued alignment to national security priorities. The Company’s recent awards across modernization, global training, aerospace, and mission readiness reinforce the value of V2X’s end-to-end solutions, ability to support global no-fail missions, and pursuit of profitable growth opportunities, in our view.
2Q26 Results. V2X reported revenue of $1.26 billion, up $178.3 million year-over-year, representing a 16.5% increase. We were at $1.2 billion. Adjusted EBITDA was $89.8 million, with a margin of 7.1%, representing an increase of 9% from the prior year. We had forecast $87 million and a 7.3% margin. Adjusted EPS came in at $1.64, up from $1.33 last year. We were at $1.44.
Noble Capital Markets Research Report Monday, August 3, 2026
Companies contained in today’s report:
ACCO Brands (ACCO)/OUTPERFORM – Post Call Commentary Codere Online (CDRO)/OUTPERFORM – Strong Execution Drives Higher 2026 Outlook Perfect (PERF)/MARKET PERFORM – Merger Agreement Signed; Share Performance Now Tied to Closing
ACCO Brands (ACCO/$4.22 | Price Target: $9) Joe Gomes [email protected] | 561-999-2262 Post Call Commentary Rating: OUTPERFORM
Mixed Operating Environment. While parts of the operating business are performing well, such as EPOS and back-to-school, other segments remain challenged, especially the International segment both economically and geopolitically, and Brazil as we await elections there. Nonetheless, we remain confident in management’s ability to navigate the environment and emerge even stronger with increased market share.
Capital. At quarter’s end, ACCO had $106.4 million of cash and equivalents on the balance sheet. Consolidated leverage ratio at quarter’s end was 4.3x and is expected to end the year in the 3.7x-3.9x range. At quarter’s end, there was approximately $205 million available for borrowing under the revolver. We believe ACCO is well positioned to fund both organic and inorganic growth opportunities.
Codere Online (CDRO/$9.18 | Price Target: $16) Michael Kupinski [email protected] | (561) 994-5734 Jacob Mutchler [email protected] | Strong Execution Drives Higher 2026 Outlook Rating: OUTPERFORM
Strong Quarter Across Core Markets. Codere Online reported Q2 net gaming revenue of €69.4 million, up 27% year over year and above our €60.0 million estimate, driven by robust performance in both Spain (+25%) and Mexico (+24%). Active customers increased 12%, while average monthly spend per active customer rose 13%, demonstrating healthy customer engagement and monetization.
Profitability Continues to Improve. Adjusted EBITDA increased to €5.8 million, better than our €2.5 million estimate and €2.3 million in the prior-year period, reflecting improved marketing efficiency and operating leverage. Adjusted EBITDA margin expanded to 8.4% from 4.3% a year ago, highlighting the scalability of the company’s platform.
Perfect (PERF/$1.92) Michael Kupinski [email protected] | (561) 994-5734 Jacob Mutchler [email protected] | Merger Agreement Signed; Share Performance Now Tied to Closing Rating: MARKET PERFORM
Definitive merger agreement signed. Perfect has entered into a definitive agreement to be acquired by a consortium led by founder and CEO Alice Chang for $2.00 per share in cash. A higher bid remains possible, but unlikely given buyer protections.
Transaction risk materially reduced. The merger was unanimously approved by the Board following the recommendation of an independent Special Committee. In addition, the buyer group has secured voting support representing approximately 53.4% of the outstanding shares and 81.2% of the Company’s voting power. There is an 8% dissenting-share condition, although the controlling group’s voting support still makes shareholder approval highly likely.
Noble Capital Markets Research Report Friday, July 31, 2026
Companies contained in today’s report:
ACCO Brands (ACCO)/OUTPERFORM – First Look at 2Q26 Results AZZ (AZZ)/OUTPERFORM – AZZ Acquires Seattle Galvanizing Company, Inc. Codere Online (CDRO)/OUTPERFORM – A Standout Second Quarter DLH Holdings (DLHC)/OUTPERFORM – A New DLH Emerging Seanergy Maritime (SHIP)/OUTPERFORM – Record Second Quarter Financial Results Exceed Expectations Tectonic Metals Inc. (TETOF)/OUTPERFORM – Moving in the Right Direction Titan International (TWI)/OUTPERFORM – A Solid 2Q26 But Still Waiting on Ag Rebound
ACCO Brands (ACCO/$4.23 | Price Target: $9) Joe Gomes [email protected] | 561-999-2262 First Look at 2Q26 Results Rating: OUTPERFORM
Overview. ACCO delivered a strong second quarter, with sales and adjusted EPS exceeding both prior-year results and our estimates. In the Americas segment, sales benefited from strong back-to-school sell-in and better-than-expected performance in Mexico. The International segment faced market softness and shipment disruptions from a planned systems upgrade at ACCO’s largest distribution center in EMEA, which is now complete.
2Q26 Results. Second quarter net sales increased 5.1% to $415.1 million from $394.8 million in 2025. The increase reflected 5.7% from the EPOS acquisition and 1.7% from favorable foreign exchange. Comparable sales declined 2.3% as growth in the Americas segment’s learning and creative category was more than offset by softness in the International segment and technology peripherals globally. Net income was $14.1 million, or $0.15/sh, compared with $29.2 million, or $0.31/sh, in 2025. Adjusted net income increased to $27.4 million from $25.8 million in 2025, and adjusted EPS rose to $0.29 from $0.28 in 2025.
Acquisition of Seattle Galvanizing Company. AZZ Inc. announced the acquisition of Seattle Galvanizing Company, Inc., a privately held provider of both hot-dip and spin galvanizing solutions that is headquartered in Arlington, Washington. The acquisition expands AZZ Metal Coatings’ geographic footprint into the Pacific Northwest by establishing a platform to serve both hot-dip and spin galvanizing customers across Washington, Oregon, Idaho, Western Montana, and Alaska from two Seattle-area locations. Seattle Galvanizing Company will be integrated into AZZ Metal Coatings’ existing network of hot-dip galvanizing and spin plants, increasing its total network to 43 sites in North America.
The Pacific Northwest’s Largest Galvanizer. Founded in 1962, Seattle Galvanizing has built a strong reputation for quality, service, and technical capability and has the capacity to process over 50,000 tons of steel. The first state-of-the-art hot-dip galvanizing facility features a 45-foot kettle, the largest in the Pacific Northwest, that will enable AZZ to process larger and more complex steel structures. A second and recently completed 38,000-square-foot spin galvanizing location was purpose-built to coat small to medium-sized metal components.
Codere Online (CDRO/$9.27 | Price Target: $14) Michael Kupinski [email protected] | (561) 994-5734 George Proost [email protected] | A Standout Second Quarter Rating: OUTPERFORM
Q2 Results. The company achieved its highest quarterly revenue to date of €69.4 million, up 27% year over year and nearly 16% above our estimate of €60 million, as illustrated in Figure #1 Q2 Results. Reported adj. EBITDA of €5.8 million also beat our estimate of €2.5 million, driven primarily by exceptional World Cup engagement and robust performance in its core markets of Spain and Mexico.
World Cup Success. The company delivered strong performance around the World Cup. Total stakes during the event reached approximately €63 million, a 180% increase over the 2022 tournament’s levels. Additionally, the company acquired around 40,000 new customers during the event, with a 56% increase in unique users.
DLH Holdings (DLHC/$5.9 | Price Target: $7) Joe Gomes [email protected] | 561-999-2262 A New DLH Emerging Rating: OUTPERFORM
3QFY26 Results. Revenue for the fiscal third quarter of 2026 totaled $44.2 million, down from $83.3 million in 3Q25 and below our $50 million estimate. Gross margin of 16.7% fell from 19.1% last year and was below our 20% projection. Partly reflecting one-time charges, DLH reported a net loss of $16.8 million, or $1.16/sh, versus net income of $289,000, or $0.02/sh last year. Third quarter adjusted EBITDA came in at $3.4 million, or 7.6% of revenue, down from $8.1 million and 9.7% last year. Notably, the final CMOP contracts transitioned during the quarter.
Operating Environment. Organic growth continues to be the number one corporate priority. Organic growth will come from two sources: on-contract growth and new awards. We believe on-contract growth will drive near-term growth. Management has a number of contracts with clients that can be expanded. In terms of new business, the government procurement markets have demonstrated improved clarity and stability in recent months, marking a significant improvement in the contracting environment when compared to fiscal 2025 and earlier in 2026.
Seanergy Maritime (SHIP/$17.82 | Price Target: $28) Mark Reichman [email protected] | (561) 999-2272 Record Second Quarter Financial Results Exceed Expectations Rating: OUTPERFORM
Record Second Quarter 2026 Financial Results. Seanergy reported revenue, adj. EBITDA, and adj. EPS of $55.7 million, $41.5 million, and $1.32, respectively, compared to $37.5 million, $18.3 million, and $0.18 during the prior year period. We had projected revenue, adj. EBITDA, and adj. EPS of $54.9 million, $38.4 million, and $1.15, respectively. Second quarter financial results reflected both materially higher time charter equivalent (TCE) rates compared to the prior year quarter and lower-than-expected interest and finance costs relative to our estimates.
Updating Estimates. We have increased our FY 2026 revenue, adj. EBITDA, and adj. EPS estimates to $205.9 million, $134.2 million, and $3.70, respectively, compared to our prior estimates of $203.2 million, $131.3 million, and $3.50. Our revised estimates reflect higher time charter equivalent (TCE) rates and fewer off-hire days.
Tectonic Metals Inc. (TETOF/$1.5 | Price Target: $3.5) Mark Reichman [email protected] | (561) 999-2272 Moving in the Right Direction Rating: OUTPERFORM
Tier 1 Gold Deposit Potential. Tectonic Metals Inc. is a Canadian mineral exploration company focused on the acquisition, exploration, and advancement of gold projects in Alaska, one of the world’s premier mining jurisdictions. The company’s flagship asset is the district-scale Flat Gold Project in southwestern Alaska, which hosts a rapidly growing intrusion-related gold system with multi-million-ounce potential and remains the primary focus of exploration and resource expansion. Tectonic also owns the Tibbs Gold Project in Alaska’s Goodpaster Mining District.
Expanding the Leadership Team. Tectonic Metals recently appointed Ms. Keren Yun as Vice President, Investor Relations to lead investor relations, stakeholder engagement, and capital markets communications. Her appointment will strengthen the company’s engagement with the investment community as the company advances the Flat Gold Project and executes its district-scale exploration strategy. Ms. Yun is a strategic communications and investor relations professional with over two decades of experience working with exploration, development, and producing companies across the global mining sector. Prior to joining Tectonic, Ms. Yun led communications initiatives supporting Wyloo’s Eagle Nest Project in Ontario.
Titan International (TWI/$7.36 | Price Target: $11) Joe Gomes [email protected] | 561-999-2262 A Solid 2Q26 But Still Waiting on Ag Rebound Rating: OUTPERFORM
Overview. Titan’s second quarter results reflect solid improvement from the prior year. The Company continues to benefit from its diverse business model, even in the face of ongoing challenging Agriculture end markets. This quarter, it was the Consumer segment that drove performance. Titan’s one-stop-shop product and distribution strategy is a key element of the diverse business model, in our view.
2Q26 Results. Driven by a 27.2% increase in Consumer segment revenue, Titan’s consolidated revenue grew 5.2% to $484 million in the second quarter. This was towards the high end of management’s guidance. We were at $480 million. Adjusted EBITDA of $34 million was up 13.3% y-o-y and exceeded the high end of management’s guidance. We were at $29 million. Titan reported quarterly net income of $6.3 million, or $0.09/sh, partly driven by tariff refund recoveries.
Noble Capital Markets Research Report Thursday, July 30, 2026
Companies contained in today’s report:
Alliance Entertainment Holding (AENT)/OUTPERFORM – Governance Simplification Enhances Flexibility EuroDry (EDRY)/OUTPERFORM – Intermediate-Term Outlook Remains Favorable; Updating Estimates Ocugen (OCGN)/OUTPERFORM – OCU410 Granted RMAT Designation in Geographic Atrophy The GEO Group (GEO)/OUTPERFORM – Another New Contract
Alliance Entertainment Holding (AENT/$5.85 | Price Target: $9) Michael Kupinski [email protected] | (561) 994-5734 Jacob Mutchler [email protected] | Governance Simplification Enhances Flexibility Rating: OUTPERFORM
Governance Structure Simplified. Alliance Entertainment has amended its Certificate of Incorporation to eliminate the voting rights of its Class E common stock, leaving Class A common stockholders with exclusive voting control while preserving the Class E shares’ economic conversion rights. We view the amendment as a meaningful simplification of the company’s capital structure that should improve governance transparency.
Economic Interests Remain Unchanged. Importantly, the amendment does not affect the economic value of the Class E shares. The shares remain convertible into Class A stock upon specified triggering events and continue to participate economically on an as-converted basis, indicating that the amendment is purely a governance enhancement rather than a dilution event.
Updating Estimates. We have adjusted our second-quarter 2026 revenue, adj. EBITDA, and adj. EPS estimates to $17.4 million, $9.3 million, and $1.44, respectively, from $17.3 million, $8.4 million, and $1.18. Our estimates reflect modestly higher time charter equivalent rates and lower voyage expenses due to lower fuel costs. For FY 2026, we forecast revenue, adj. EBITDA, and adj. EPS of $66.0 million, $31.9 million, and $4.27, respectively, compared to our previous estimates of $65.3 million, $30.5 million, and $3.87.
Intermediate-Term Outlook Remains Constructive. The intermediate-term outlook for the dry bulk shipping industry remains favorable, supported by strengthening charter rates, resilient demand for iron ore, grain, and bauxite, and a highly supportive supply backdrop. A historically low order book, limited shipyard capacity, an aging global fleet, and increasingly stringent environmental regulations are expected to constrain vessel supply growth and support freight rates through 2026. While the 2027 outlook offers less certainty, EuroDry has the flexibility to respond to market conditions by increasing its fixed-rate charter coverage.
RMAT Designation Brings Regulatory Advantages For OCU410. Ocugen announced that the FDA has granted Regenerative Medicine Advanced Therapy (RMAT) designation to OCU410 for Geographic Atrophy secondary to Age-Related Macular Degeneration (GA-AMD). The RMAT designation was granted after FDA evaluation of Phase 2 data and provides significant benefits, including Fast Track and Breakthrough Therapy designations.
RMAT Designation Carries Benefits During Clinical Development. The RMAT designation is granted to drugs that address a serious condition with significant unmet need. There are several benefits, including more frequent FDA communications and guidance during clinical trials and the BLA process. This increased FDA contact could allow Ocugen to address development questions earlier, reducing regulatory uncertainty and streamlining the review.
The GEO Group (GEO/$29.95 | Price Target: $35) Joe Gomes [email protected] | 561-999-2262 Another New Contract Rating: OUTPERFORM
New Contract. Hot on the heels of the Big Horn facility announcement, The GEO Group, Inc. has entered into a five-year support services contract with U.S. Immigration and Customs Enforcement (“ICE”) for the activation of a federal immigration processing center at the GEO-owned, 1,320-bed Rivers Facility in Winton, North Carolina. Yesterday’s announcement continues new award momentum, which we believe will continue into the second half of 2026.
Details. The support services contract is expected to generate approximately $80 million in annual revenues in the first full year of operations. GEO’s support services are expected to include the exclusive use of the Facility by ICE, along with security, maintenance, and food services, as well as access to recreational amenities, medical care, and legal counsel.
Noble Capital Markets Research Report Wednesday, July 29, 2026
Companies contained in today’s report:
GeoVax Labs (GOVX)/OUTPERFORM – GeoVax Reports 2Q26 With Clinical Study Plans Moving Forward Travelzoo (TZOO)/OUTPERFORM – Investment Quarter Masks Long-Term Value
GeoVax Labs (GOVX/$0.73 | Price Target: $10) Robert LeBoyer [email protected] | (212) 896-4625 GeoVax Reports 2Q26 With Clinical Study Plans Moving Forward Rating: OUTPERFORM
GeoVax Reported 2Q26 With Updates For GEO-MVA and Oncology Programs. GeoVax reported a 2Q26 net loss of $4.4 million or $(0.97) per share, lower than our expected loss of $5.8 million. R&D expenses were lower than we projected due to strategic changes, with priority given to preparations for the upcoming Phase 3 trial of GEO-MVA in MPox and the Phase 2 trial of Gedeptin in oncology. Cash on June 30, 2026 was approximately $3.1 million.
Strategic Changes Lowered The 2Q26 Loss. As discussed in our Research Note on May 27, GeoVax will focus on GEO-MVA in infectious diseases and Gedeptin in oncology. These programs have established regulatory pathways, patient needs, and market potential.
Travelzoo (TZOO/$7.55 | Price Target: $16) Michael Kupinski [email protected] | (561) 994-5734 Jacob Mutchler [email protected] | Investment Quarter Masks Long-Term Value Rating: OUTPERFORM
Accelerated membership investment weighed heavily on Q2 results. Revenue declined 3% to $23.2 million, while Travelzoo reported a $2.8 million operating loss and a non-GAAP operating loss of $2.1 million. The decline reflected geopolitical uncertainty across Travelzoo’s markets and a deliberate increase in member-acquisition spending.
The recurring-revenue strategy is gaining measurable traction. Membership and subscription revenue increased to approximately $5.0 million in Q2 from $3.0 million in the prior-year period, while deferred revenue rose 54% from year-end to $13.4 million. Membership renewals reached a record level.
Noble Capital Markets Research Report Tuesday, July 28, 2026
Companies contained in today’s report:
Alliance Resource Partners (ARLP)/OUTPERFORM – Second Quarter 2026 Review and Outlook Beasley Broadcast Group (BBGI)/OUTPERFORM – Building a More Resilient Local Media Platform First Phosphate Corp. (FRSPF)/OUTPERFORM – Gaining Momentum Perfect (PERF)/MARKET PERFORM – Fundamentals Overshadowed by Pending Buyout
Alliance Resource Partners (ARLP/$25.63 | Price Target: $33.5) Mark Reichman [email protected] | (561) 999-2272 Second Quarter 2026 Review and Outlook Rating: OUTPERFORM
Second Quarter Financial Results. Compared to the prior year period, second-quarter 2026 revenue increased to $551.6 million from $547.5 million due to strong oil & gas royalty revenues, increased coal sales volumes, and higher other revenues, partially offset by a lower average realized coal sales price per ton. Adjusted EBITDA increased 14.7% to $185.7 million compared to $161.9 million in the second quarter of last year. Adjusted net income attributable to ARLP increased to $79.6 million, or $0.61 per unit, compared to $59.4 million, or $0.46 per unit, during the prior year period. Second quarter financial results were largely in line with our estimates. We had projected total revenue of $553.5 million, adj. EBITDA of $181.2 million, and EPU of $0.62.
Oil & Gas Royalties Remain a Key Growth Driver. The oil & gas royalties segment delivered record quarterly revenue and segment adjusted EBITDA, driven by increased volumes and higher commodity prices. On July 1, ARLP closed the $206.2 million AllDale III and IV acquisition. Crude oil volumes are now expected to be in the range of 1.95 million to 2.05 million barrels, natural gas volumes are expected to be in the range of 10.0 million to 10.5 million MCF, and liquids volumes are expected to be in the range of 1.1 million to 1.2 million barrels.
Beasley Broadcast Group (BBGI/$21 | Price Target: $31) Michael Kupinski [email protected] | (561) 994-5734 Jacob Mutchler [email protected] | Building a More Resilient Local Media Platform Rating: OUTPERFORM
Executing a multi-year turnaround strategy. Management is focused on three strategic priorities: stabilizing local direct advertising, expanding higher-margin owned-and-operated digital products, and strengthening the balance sheet through disciplined deleveraging. We believe successful execution could materially improve the company’s earnings profile over the next several years.
Digital mix continues to improve. Digital revenue represented more than 25% of total company revenue during the first quarter of 2026, while owned-and-operated digital products increased to approximately 65% of digital revenue. We believe the improving revenue mix should support higher margins, stronger customer retention, and improved free cash flow generation over time.
First Phosphate Corp. (FRSPF/$1.06 | Price Target: $2) Mark Reichman [email protected] | (561) 999-2272 Gaining Momentum Rating: OUTPERFORM
Building North America’s LFP Supply Chain. First Phosphate Corp. is a Québec-based critical minerals development company focused on establishing a fully integrated North American lithium iron phosphate (LFP) battery materials supply chain. First Phosphate is dedicated exclusively to supplying the rapidly expanding LFP battery market through the production of high-purity igneous phosphate, purified phosphoric acid, and iron phosphate precursor materials.
Differentiated with Significant Competitive Advantages. First Phosphate benefits from significant competitive advantages and differentiation within both the phosphate industry and the broader critical minerals sector. Most phosphate producers worldwide focus on fertilizer markets using sedimentary phosphate deposits that require significant upgrading and are generally less suitable for producing battery-grade phosphoric acid. By contrast, First Phosphate is exclusively targeting the LFP battery industry using rare high-purity igneous phosphate, allowing it to focus on higher-value specialty battery materials.
Perfect (PERF/$1.93) Michael Kupinski [email protected] | (561) 994-5734 Jacob Mutchler [email protected] | Fundamentals Overshadowed by Pending Buyout Rating: MARKET PERFORM
Another quarter of improving profitability. Revenue remained stable while higher gross margins and disciplined expense management drove another quarter of improving earnings quality.
AI SaaS model continues to scale. Gross margins remained above 80%, demonstrating the attractive economics of the company’s subscription-driven AI platform and expanding operating leverage.
Noble Capital Markets Research Report Friday, July 24, 2026
Companies contained in today’s report:
Aurania Resources (AUIAF)/OUTPERFORM – Board Member Assumes Expanded Role Resources Connection (RGP)/OUTPERFORM – Reports 4Q26 Results In-line with Expectations SelectQuote (SLQT)/OUTPERFORM – Q4 Preview—Building Toward a Cash Flow Inflection
Aurania Resources (AUIAF/$0.14 | Price Target: $0.3) Mark Reichman [email protected] | (561) 999-2272 Board Member Assumes Expanded Role Rating: OUTPERFORM
Supporting Project Advancement. Aurania Resources has appointed current independent director Mr. Thomas Ullrich as Special Advisor, effective immediately, to support the advancement of the company’s strategic projects. Working closely with President and Chief Executive Officer Dr. Keith Barron, Mr. Ullrich will provide strategic guidance on operational and mineral exploration activities, evaluate strategic opportunities, assist with project management, strengthen industry relationships, and help prioritize key initiatives across the company’s portfolio while continuing to serve on the Board of Directors.
Leveraging Experience and Expertise. Mr. Ullrich offers more than 35 years of experience in mineral exploration and geoscience, with expertise encompassing technical exploration, project evaluation, and capital markets. He currently serves as Chief Executive Officer and a director of Aston Bay Holdings Ltd. and previously held senior technical roles with Antofagasta Minerals and Almaden Minerals, where he managed the drill program that led to the discovery of the Ixtaca silver-gold deposit in Mexico. We think Mr. Ullrich’s expanded role will enhance Aurania’s ability to advance its exploration and development initiatives to create long-term shareholder value.
Overview. Resources Connection’s 4Q26 results were mostly in line with management expectations. Overall industry conditions were consistent with 3Q26, suggesting the market is stabilizing. During the quarter, RGP continued to make focused investments to support future growth, which we are hopeful will occur in 2HFY27.
4Q26 Details. Revenue of $106.1 million was down 18.3% on a constant currency basis y-o-y but was within management’s $104-$109 guide. 4Q26 also had one less week of billable activity compared to 4Q25. Gross margin of 37.6% was down from 40.2% y-o-y but exceeded the top end of management’s guide. Adjusted EPS was a net loss of $0.07 compared to EPS of $0.16 in 4Q25.
SelectQuote (SLQT/$0.7 | Price Target: $5) Michael Kupinski [email protected] | (561) 994-5734 Jacob Mutchler [email protected] | Q4 Preview—Building Toward a Cash Flow Inflection Rating: OUTPERFORM
Q4 Should Reinforce Improving Cash Flow Story. Although fourth quarter revenue should normalize following the seasonally strong Medicare enrollment period, we expect another quarter of healthy profitability and cash generation that reinforces management’s expectation for a significant cash flow acceleration entering fiscal 2027.
Senior Business Demonstrates Structural Earnings Strength. Even amid continued Medicare Advantage disruption, the Senior business has consistently produced EBITDA margins above 25% during enrollment periods. We expect another solid quarter as disciplined marketing spend and strong customer retention continue to support attractive economics.
Noble Capital Markets Research Report Thursday, July 23, 2026
Companies contained in today’s report:
Cadrenal Therapeutics (CVKD)/OUTPERFORM – Strategic Changes Create A New Cardiac Acute Critical Care Franchise Seanergy Maritime (SHIP)/OUTPERFORM – Updating Estimates; Growth Outlook Remains Favorable
Cadrenal Therapeutics (CVKD/$2.1 | Price Target: $12) Robert LeBoyer [email protected] | (212) 896-4625 Strategic Changes Create A New Cardiac Acute Critical Care Franchise Rating: OUTPERFORM
Advancing Products Through Partnerships. Cadrenal announced that it has modified its development strategy and product pipeline to focus on therapies for cardiac surgical care and orphan cardiac conditions. It now plans to advance the products through development partnerships, licensing, and commercialization agreements to minimize capital expenditures. This announcement formalizes the transition we have seen over the past several months.
Building A “Cardiac Acute Critical Care Franchise”. Cadrenal has refined its clinical focus to late-stage critical-care cardiovascular products for conditions with no effective treatments. It now plans to form partnerships for CAD-1005, frunexian, and tecarfarin, avoiding the large capital raises needed to fund further clinical trials.
Updating Estimates. We have increased our 2Q 2026 revenue, adj. EBITDA, and adj. EPS estimates to $54.9 million, $38.4 million, and $1.15, respectively, from $50.0 million, $35.2 million, and $1.00. Our estimates reflect higher time charter equivalent rates than previously estimated. Moreover, we have lowered our estimates for vessel operating expenses in the second quarter and increased our estimate for general and administrative expenses in the second and third quarters. For FY 2026, we forecast revenue, adj. EBITDA, and adj. EPS of $203.2 million, $131.3 million, and $3.50, respectively, compared to our previous estimates of $198.3 million, $130.2 million, and $3.45.
Constructive Outlook. Seanergy’s outlook remains constructive, supported by favorable Capesize market fundamentals, a disciplined capital allocation strategy, and a multi-year fleet modernization program that positions the company to benefit from what we think will be a structurally attractive market through 2029. Following a strong first quarter in which the company reported significantly higher earnings and cash flow, we expect the momentum to continue, with second quarter time charter equivalent (TCE) rates projected to be approximately $31,430 per day.
Noble Capital Markets Research Report Wednesday, July 22, 2026
Companies contained in today’s report:
FreightCar America (RAIL)/OUTPERFORM – Acquisition of Southern Parts & Equipment, Inc. Supports Aftermarket Expansion Strategy Kratos Defense & Security (KTOS)/OUTPERFORM – More New Business Kuya Silver (KUYAF)/OUTPERFORM – Bethania Delivers Record Quarter as Production Gains Momentum
FreightCar America (RAIL/$7.81 | Price Target: $15) Mark Reichman [email protected] | (561) 999-2272 Acquisition of Southern Parts & Equipment, Inc. Supports Aftermarket Expansion Strategy Rating: OUTPERFORM
Acquisition of Southern Parts & Equipment, Inc. FreightCar America announced the acquisition of Southern Parts & Equipment, Inc., a Monroe, Georgia-based distributor of reconditioned, new, and used railcar parts and equipment. The transaction, funded with cash, represents the company’s second acquisition in the railcar aftermarket segment within the past year.
A Growing Aftermarket Platform. The acquisition advances RAIL’s strategy of building a larger, more diversified aftermarket business that generates recurring revenue and reduces the cyclicality of new railcar manufacturing. Founded in 1988, SP&E has established a strong reputation serving railcar repair shops and private railcar owners. The transaction expands FreightCar’s customer base, enhances sourcing capabilities, and creates additional cross-selling opportunities across its growing aftermarket platform.
Kratos Defense & Security (KTOS/$48.21 | Price Target: $145) Joe Gomes [email protected] | 561-999-2262 More New Business Rating: OUTPERFORM
New Business. Kratos continues to receive new business, confirming the large growth opportunities available, in our view. The new business highlights the Company’s operating philosophy of having the right products, in the right space, at the right time. The recent awards add to the pile of new business Kratos has been awarded so far in 2026.
C-UAS Award. Kratos was awarded a sole-source, single-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract for approximately $156 million by the U.S. Department of Energy’s National Nuclear Security Administration (NNSA) Office of Secure Transportation (OST) in support of Project Solar Shield. Under this new contract award, Kratos will provide mobile Counter-Unmanned Aircraft System (C-UAS) platforms designed to support OST’s critical National Security mission. The OST is responsible for the safe and secure ground and air transportation of nuclear weapons, weapon components, and special nuclear materials. Kratos was selected following a rigorous technical evaluation.
Kuya Silver (KUYAF/$0.47 | Price Target: $2.5) Mark Reichman [email protected] | (561) 999-2272 Bethania Delivers Record Quarter as Production Gains Momentum Rating: OUTPERFORM
Strong Operating Momentum. Kuya Silver reported another record quarter at its Bethania mine, with mined mineralized material increasing 66% sequentially to 5,097 tonnes. The company also achieved record quarterly silver production of 23,912 ounces or 30,559 silver-equivalent ounces, along with record monthly production in June as underground development, mine sequencing, and production rates continued to improve. Management expects recoveries and grades to continue strengthening as the operation advances toward steady-state production.
Quarterly Financial Highlights. Revenue for the quarter totaled approximately $1.25 million, generated primarily from silver sales, which accounted for 87% of total revenue. Metal sold included 17,450 ounces of silver or 20,006 ounces of silver equivalent. The company realized an average silver selling price of $72 per ounce during the quarter, benefiting from a favorable silver price environment. While quarterly silver sales volumes were lower than the prior year due to the timing of sales, higher realized silver prices supported revenue growth as production continued to ramp toward higher sustainable mining rates. We expect the company to release full second quarter financial and operational results in mid-August.
Noble Capital Markets Research Report Tuesday, July 21, 2026
Companies contained in today’s report:
Greenwich LifeSciences, Inc. (GLSI)/OUTPERFORM – Modifications To Phase 3 FLAMINGO-01 Trial Raise Probability Of Success NN (NNBR)/OUTPERFORM – Further Expansion in the Defense Industry T3 Defense (DFNS)/OUTPERFORM – Stock Split Complete
Greenwich LifeSciences, Inc. (GLSI/$14.07 | Price Target: $45) Robert LeBoyer [email protected] | (212) 896-4625 Modifications To Phase 3 FLAMINGO-01 Trial Raise Probability Of Success Rating: OUTPERFORM
Trial Modifications Announced. Greenwich Pharmaceuticals announced modifications to the Phase 3 FLAMINGO-01 trial testing GLS-100 for the prevention of recurrent breast cancer. Several changes reflect preliminary findings and allow for increased enrollment in the pivotal arm of the trial. We believe the changes increase the likelihood of positive results in the interim and the final analyses, as well as potentially doubling the market.
The Original Phase 3 Design. The original trial design screened patients for HLA type, an immune system classification. Patients with HLA-A*02, the most common type, were randomized into two double-blind arms testing GLSI-100 against a placebo control. The non-HLA-A*02 patients were entered into an open-label arm. Following the standard of care treatment for breast cancer, patients were given six monthly doses of GLSI-100, then boosters every 6 months for 11 total doses.
NN (NNBR/$3.48 | Price Target: $6) Joe Gomes [email protected] | 561-999-2262 Further Expansion in the Defense Industry Rating: OUTPERFORM
Contract Manufacturing. NN continues to expand into new and adjacent segments, providing the Company with strong growth opportunities, in our view. Most recently, NN successfully entered the Tier 1 contract manufacturing industry for firearm components in the United States market.
Details. NN’s contract manufacturing agreement is to mass-produce completed firearms products for a leading provider of firearms products in the U.S. This new business begins in the third quarter and will continue ramping up through 2028. This new business is expected to add between $12 million and $15 million in sales. Due to the multipart complexity of this new product line, these products are now the highest-priced products in the Company’s portfolio of new products.
T3 Defense (DFNS/$4.26 | Price Target: $20) Joe Gomes [email protected] | 561-999-2262 Stock Split Complete Rating: OUTPERFORM
Reverse Stock Split. As outlined in prior reports, T3 underwent a 1-for-125 reverse stock split to regain compliance with Nasdaq regulations. As a result, the number of outstanding shares declined from approximately 139.8 million to approximately 1.1 million. We adjusted our model to reflect the impact on earnings per share.
Impact. Assuming the stock split only impacts the forward quarters, the 2Q adjusted net loss increases to $2.87/sh, 3Q to a loss of $2.16/sh, and 4Q to a net loss of $1.75/sh, up from a previous projected net loss of $0.06/sh, $0.03/sh, and $0.02 per share, respectively, Full year net loss increases to $3.90/sh, up from a prior full year net loss forecast of $0.50/sh. If we adjusted 1Q26 EPS loss to the 1.1 million outstanding shares, full-year net loss rises to $30.26/sh, which includes a number of one-time non-cash charges. The share change does not impact our estimates for adjusted EBITDA, which remains at a loss of $6 million for 2026.
Noble Capital Markets Research Report Friday, July 17, 2026
Companies contained in today’s report:
Kratos Defense & Security (KTOS)/OUTPERFORM – Building Momentum Resolution Minerals Ltd (RLMLF)/OUTPERFORM – Resolution Minerals Receives FAST-41 Designation for Golden Gate T3 Defense (DFNS)/OUTPERFORM – Increases Reverse Split Ratio to 1-for-125 from 1-for-50
Kratos Defense & Security (KTOS/$46.96 | Price Target: $145) Joe Gomes [email protected] | 561-999-2262 Building Momentum Rating: OUTPERFORM
Momentum. Recent awards, facilities expansion, world events, and increasing defense spending worldwide are combining to provide positive momentum to Kratos’ business, in our view. With proven, existing products focused on key areas of new Defense priorities, we continue to believe Kratos is well-positioned to capitalize on the current operating environment.
$400M Hypersonics. The Company recently received approximately $400 million in funding from the Department of War (DoW) related to certain hypersonic systems and other National Security related programs. Notably, beginning in June and both increasing and accelerating into July, Kratos is seeing significant funding from the DoW, which is expected to accelerate the Company’s organic growth rate, increase operating cash receipts, while reducing customer receivables, inventory, and assets where Kratos had previously “leaned forward” to ensure Kratos met or exceeded customers’ schedule-related and other expectations.
Resolution Minerals Ltd (RLMLF/$0.04 | Price Target: $0.15) Mark Reichman [email protected] | (561) 999-2272 Resolution Minerals Receives FAST-41 Designation for Golden Gate Rating: OUTPERFORM
Golden Gate FAST-41 Designation. Resolution Minerals’ Golden Gate Project in Idaho has been granted FAST-41 Transparency Coverage by the U.S. Federal Permitting Council, making it the Company’s second project to receive the designation after Antimony Ridge. The designation highlights the strategic importance of the Horse Heaven Project as a domestic source of tungsten, antimony, and gold and is expected to accelerate permitting through enhanced federal coordination and oversight.
Golden Gate Plan of Operations. The Golden Gate Project is part of Resolution’s 15,000-acre Horse Heaven Project, which also includes the Antimony Ridge target, the Johnson Creek Tungsten Mill, and historical tungsten stockpiles. The Company has submitted a Plan of Operations that includes construction of new access roads, up to 340 drill holes and 2,000 feet of trenching, while continuing a fully funded 45-hole drilling program to advance resource definition.
T3 Defense (DFNS/$0.05 | Price Target: $0.8) Joe Gomes [email protected] | 561-999-2262 Increases Reverse Split Ratio to 1-for-125 from 1-for-50 Rating: OUTPERFORM
Increased Ratio. Yesterday, T3 announced that, given the recent stock activity, the T3 Board of Directors determined to significantly increase the ratio from the 1-for-50 disclosed in July 13th’s 8-K to 1-for-125. T3 Defense still expects that its common stock will open for trading on the Nasdaq Capital Market on a reverse split-adjusted basis on July 20, 2026, under the existing trading symbol “DFNS”.
Impact. At the Effective Date of the reverse stock split, every 125 shares of common stock outstanding and held of record by each stockholder of the Company will be automatically reclassified into one new share of Common Stock, reducing the number of shares of common stock issued and outstanding from approximately 139.8 million to approximately 1 million. We will update our models and price target following the split.
Noble Capital Markets Research Report Thursday, July 16, 2026
Companies contained in today’s report:
Century Lithium Corp. (CYDVF)/OUTPERFORM – Century Lithium Advances Commercial Readiness CoreCivic, Inc. (CXW)/OUTPERFORM – Redeeming 4.75% Notes Power Metallic Mines Inc. (PNPNF)/OUTPERFORM – Advancing the Nisk Project Toward Development T3 Defense (DFNS)/OUTPERFORM – Reverse Split The GEO Group (GEO)/OUTPERFORM – New Contract with ICE; Raising Price Target
Century Lithium Corp. (CYDVF/$0.18 | Price Target: $3.05) Mark Reichman [email protected] | (561) 999-2272 Century Lithium Advances Commercial Readiness Rating: OUTPERFORM
Angel Island Lithium Carbonate to High-Purity Lithium Metal. Century Lithium announced that lithium carbonate produced from its wholly owned Angel Island Lithium Project in Nevada was successfully converted into high-purity lithium metal by Alpha-En Corporation using its proprietary extraction and electrodeposition technology and subsequently incorporated into cylindrical battery cells manufactured by EaglePicher Technologies. The work was completed under the U.S. Army Small Business Innovation Research (SBIR) program, which supports the development of technologies critical to national defense.
Strong Battery Performance. Testing demonstrated that the lithium metal anodes met EaglePicher’s performance specifications and delivered higher operating voltages and improved power performance compared with control cells. These results highlight the suitability of Angel Island lithium for advanced, high-energy battery applications while validating the project’s potential to supply a domestic source of battery-grade lithium for defense-related technologies.
CoreCivic, Inc. (CXW/$31.09 | Price Target: $35) Joe Gomes [email protected] | 561-999-2262 Redeeming 4.75% Notes Rating: OUTPERFORM
Redemption. CoreCivic has elected to redeem in full the 4.75% Senior Notes due 2027 that remain outstanding on August 12, 2026. This was an expected use of funds from the recently announced sale of two facilities to the Federal government. As of July 13, 2026, the principal amount of the outstanding 2027 Notes was $238,468,000. We anticipate additional debt reduction with a portion of the remaining sale proceeds.
Detail. The 2027 Notes will be redeemed at a redemption price equal to 100.000% of the principal amount of the then-outstanding 2027 Notes, plus the applicable “make-whole” premium specified in the indenture, as supplemented, governing the 2027 Senior Notes, plus accrued and unpaid interest to, but not including, the Redemption Date. We estimate the annual interest expense savings to be approximately $11.3 million.
Power Metallic Mines Inc. (PNPNF/$0.74 | Price Target: $2.65) Mark Reichman [email protected] | (561) 999-2272 Advancing the Nisk Project Toward Development Rating: OUTPERFORM
Building Momentum. Power Metallic is advancing the Nisk Project from exploration toward development, with a maiden NI 43-101 mineral resource estimate expected by the end of July 2026, followed by a Preliminary Economic Assessment which we anticipate could be completed in December 2026. The addition of mining executive Mr. Christopher Beal as Vice President of Operations further strengthens the company’s technical and operational capabilities as it progresses toward engineering studies and future development.
Drilling Continues to Deliver. Recent drilling reinforced the exceptional quality of the Lion Zone, highlighted by an intercept of 36.42 meters grading 2.83% copper equivalent, including 6.0 meters grading 12.38% copper equivalent. Combined with consistently high-grade drill results, strong metallurgical recoveries, and multiple target areas, the Nisk Project has the potential to become a significant polymetallic mining district.
T3 Defense (DFNS/$0.07 | Price Target: $0.8) Joe Gomes [email protected] | 561-999-2262 Reverse Split Rating: OUTPERFORM
Reverse Split. T3 is implementing a 50-for-1 reverse stock split. The reverse stock split will become effective as of 12:01 a.m., Eastern Time, on July 20, 2026, and the Company’s common stock will begin trading on the Nasdaq Global Market on a split-adjusted basis when the market opens on July 20, 2026.
Rationale. The Company is implementing the reverse stock split to raise the per-share bid price of the Company’s common stock above $1.00 per share and bring the Company back into compliance with Nasdaq Listing Rule 5550(a). The Company will have regained compliance once the Company’s shares trade at or above $1.00 for a minimum of 10 consecutive trading days, at which time Nasdaq will provide the Company with notice that it has regained compliance.
The GEO Group (GEO/$29.82 | Price Target: $35) Joe Gomes [email protected] | 561-999-2262 New Contract with ICE; Raising Price Target Rating: OUTPERFORM
New Contract. The GEO Group has entered into a five-year support services contract with U.S. Immigration and Customs Enforcement (“ICE”) for the activation of a federal immigration processing center at the 1,188-bed Big Horn Facility. GEO has entered into a lease agreement with the Facility owner. We view the new award positively and expect to see more such announcements going forward as ICE continues to seek out partners to assist the Agency in fulfilling its mission.
Details. The support services contract is expected to generate approximately $85 million in annual revenues in the first full year of operations, excluding transportation revenue. GEO’s support services are expected to include the exclusive use of the facility by ICE, along with security, maintenance, and food services, as well as access to recreational amenities, medical care, and legal counsel.
New unemployment filings dropped for a second straight week, pointing to a labor market that stays steady even as hiring cools, giving the Federal Reserve room to focus on inflation. But a separate report showed the goods trade deficit widening to its largest in over a year, a reminder that the growth story beneath the calm jobs data is more complicated.
Initial claims for state unemployment benefits fell by 4,000 to a seasonally adjusted 203,000 for the week ended August 22, the Labor Department said, below the 208,000 economists expected and a second straight weekly decline. Claims have spent the year in a tight 189,000–230,000 band and are now near the low end, signaling that employers aren’t shedding workers even if they aren’t hiring aggressively. Despite a surprise dip in July payrolls, unemployment edged down again to a historically low 4.1%.
Continuing claims, a rough proxy for how hard it is to find new work, fell 18,000 to 1.778 million, the lowest in a month. That week also aligned with the survey period for the August payrolls report, giving it extra weight.
Some analysts argue the picture is steadier than the official figures imply. Private data from payroll processors and labor-market analytics firms point to a job market in better balance than the choppier government numbers suggest, with modest but consistent private hiring roughly at the pace needed to keep unemployment flat.
A stable labor market frees the Fed to keep leaning against inflation, which has run above its 2% target for 65 consecutive months. That’s the backdrop as policymakers gather in Jackson Hole, where Chair Kevin Warsh delivers a closely watched keynote Friday, under pressure to address whether inflation is still a threat.
He isn’t short on colleagues sounding the alarm. Three voting members dissented last month against holding rates at 3.50%–3.75%, and the Fed’s preferred inflation gauge held at 3.7%. Kansas City Fed President Jeffrey Schmid called inflation stubborn and sticky; Chicago Fed President Austan Goolsbee named it his top worry.
The goods trade deficit widened to $118.8 billion in July from $101.4 billion in June, the largest since March 2025, when importers front-loaded ahead of “Liberation Day” tariffs. It’s an awkward figure for a White House leaning on tariffs to shrink the gap.
Exports slipped 2.9% to $199.4 billion, dragged by an 11.2% drop in industrial goods. Imports climbed 3.7% to $318.2 billion, powered by an 11.3% surge in capital-goods imports tied to the AI buildout. Oxford Economics’ Matthew Martin expects that demand to persist into 2027. But the near-term cost is to GDP, with trade likely a drag for a fourth straight quarter, an estimated one-point hit in Q3 after subtracting 1.14 points in Q2.
Two reports, two signals. Jobs data says the foundation is intact, giving the Fed cover to focus on prices; trade data says the AI boom lifting markets is also weighing on output. Warsh’s Friday remarks are the next place to look.
VNCE Will Own OVO’s Operating Business and a 5% Stake in OVO’s Intellectual Property Alongside Authentic Brands Group and OVO Co-Founder Aubrey “Drake” Graham
Transaction Expected to be Accretive to VNCE in Fiscal 2027
VNCE Expects to Deliver Second Quarter Fiscal 2026 Results At the High End of Guidance
NEW YORK–(BUSINESS WIRE)– Vince Holding Corp. (Nasdaq: VNCE) (“VNCE” or the “Company”), a global retail platform today announced it has completed the acquisition of the operating business of October’s Very Own (“OVO”), a globally recognized lifestyle brand. VNCE now will own and operate OVO’s business as OVO’s core apparel and retail licensee, marking the first expansion of its multi-brand platform strategy beyond Vince, and will build on OVO’s existing operations using its scale and infrastructure to support the brand’s next phase of growth.
This transaction also further deepens VNCE’s partnership with Authentic Brands Group (“Authentic”), a global entertainment platform, who has acquired a majority stake in OVO’s intellectual property (“OVO IP”). A portion of the proceeds from the sale of OVO IP will be used to strengthen OVO’s balance sheet and support VNCE’s growth strategy for the business. This transaction combines Authentic’s brand management expertise with VNCE’s proven capabilities in merchandising and operating ready-to-wear brands, creating a new revenue stream for VNCE. As part of this expanded partnership, VNCE will own 5% of the OVO IP and has entered into a long-term license agreement for use of the OVO IP.
This transaction advances VNCE’s strategy to diversify its revenue and earnings by leveraging its platform and operating expertise. This transaction is expected to:
Provide VNCE access to the fast growing global streetwear market.
Fuel OVO’s U.S. growth by:
Store and e-commerce expansion by leveraging VNCE’s scale and infrastructure.
Launch OVO’s wholesale business through VNCE’s established wholesale relationships with key national department store partners.
Optimize OVO’s operations while design and creative functions for each brand remain separate.
Give VNCE the Canadian-based infrastructure to open Vince stores and expand e-commerce and wholesale.
Founded by Aubrey “Drake” Graham, Oliver El-Khatib, and Noah “40” Shebib, OVO has established itself as one of the most recognized brands in contemporary streetwear. Known for its distinctive owl logo and black-and-gold aesthetic, the brand has built its reputation on collaboration-led product drops and a close connection to its customer base. OVO currently operates 12 stores across Canada, the United States, and the United Kingdom, in addition to its e-commerce platform.
“We are thrilled to welcome OVO into our portfolio and to partner with Drake and Authentic in building on the brand’s strong foundation to support its next phase of growth,” said Brendan Hoffman, Chief Executive Officer of VNCE. “This transaction also deepens our relationship with Authentic Brands Group, a partner supporting our multi-brand platform strategy to broaden our portfolio of brands, business models, and distribution channels, and drive long-term value for all stakeholders. We are committed to preserving the authenticity and meaningful customer relationships that have driven OVO’s success to date.”
“We are proud to welcome OVO to Authentic and to expand our partnership with VNCE, whose operating expertise makes them an ideal partner to grow the business,” said Jamie Salter, Founder and Executive Chairman of Authentic. “Together, we see significant opportunity to introduce OVO into new categories, channels, and markets while staying true to the creative vision and community that have made the brand so special. The success we’ve had partnering with VNCE gives us great confidence in their stewardship of OVO’s business and we look forward to exploring future opportunities to utilize the VNCE platform.”
“We’re just a couple kids from Toronto who started something we believed in, here we are 20 years later, same kids with bigger dreams. Authentic and VNCE are the perfect partners to help us continue to grow,” said Drake.
Transaction Details
Under the terms of the transaction, Authentic formed a new subsidiary which holds OVO’s IP, under which Authentic owns 51%, Drake owns 44%, and VNCE owns the remaining 5%. A portion of the proceeds from the sale of OVO’s IP was used to strengthen the balance sheet of OVO’s operating business, which VNCE then acquired. VNCE remains well-capitalized, with a strong balance sheet that supports both this transaction and its continued growth in the Vince business.
VNCE and Authentic have entered into a license agreement granting VNCE the exclusive right to use OVO’s IP to manufacture and sell licensed apparel worldwide, in exchange for payment of a royalty fee to Authentic.
VNCE’s acquisition includes all of OVO’s existing operating companies, assets and liabilities, including its retail stores, e-commerce platform, and wholesale relationships across Canada, the United States, and the United Kingdom. VNCE will retain OVO’s existing team and continue to operate the business from its Toronto headquarters as it builds out the brand’s next phase of growth.
Vince and OVO will maintain separate brand operations and creative teams, with VNCE serving its contemporary customer and OVO continuing to serve its streetwear audience.
Second Quarter Fiscal 2026 Outlook
Based on continued momentum in the business, VNCE expects to deliver Q2 fiscal 2026 results at the high-end of its prior guidance ranges, excluding any benefit from tariff refunds.
These amounts are based on currently available information and are subject to change, including potential adjustments related to customary financial closing procedures and period-end accruals for the fiscal quarter ending August 1, 2026.
The Company plans to share more on its results when its report its second quarter fiscal 2026 results by September 15, 2026.
DISCLOSURES REGARDING FORWARD-LOOKING STATEMENTS
This document, and any statements incorporated by reference herein, contain forward-looking statements under the Private Securities Litigation Reform Act of 1995. Forward-looking statements include the statements under “Transaction Details” and “Second Quarter Fiscal 2026 Outlook” above as well as statements regarding, among other things, our current expectations about possible or assumed future results of operations of the Company and are indicated by words or phrases such as “may,” “will,” “should,” “believe,” “expect,” “seek,” “anticipate,” “intend,” “estimate,” “plan,” “target,” “project,” “forecast,” “envision” and other similar phrases. Although we believe the assumptions and expectations reflected in these forward-looking statements are reasonable, these assumptions and expectations may not prove to be correct and we may not achieve the results or benefits anticipated. These forward-looking statements are not guarantees of actual results, and our actual results may differ materially from those suggested in the forward-looking statements. These forward-looking statements involve a number of risks and uncertainties, some of which are beyond our control, including, without limitation: the expected effects of the acquisition of OVO’s existing operations, assets and liabilities (the “OVO Acquisition”) on the Company; our ability to integrate OVO with the Company, changes to and unpredictability in the trade policies and tariffs imposed by the U.S. and the governments of other nations; general economic conditions; our ability to maintain adequate cash flow from operations or availability under our revolving credit facility to meet our liquidity needs; restrictions on our operations under our credit facilities; our ability to improve our profitability; our ability to maintain our larger wholesale partners; our ability to accurately forecast customer demand for our products; our ability to maintain the license agreement relating to the Vince brand with ABG Vince; ABG Vince’s expansion of the Vince brand into other categories and territories; ABG Vince’s approval rights and other actions; our ability to realize the benefits of our strategic initiatives; our ability to make lease payments when due; our ability to open retail stores under favorable lease terms and operate and maintain new and existing retail stores successfully; our operating experience and brand recognition in international markets; our ability to remediate the identified material weakness in our internal control over financial reporting; our ability to comply with domestic and international laws, regulations and orders; increased scrutiny regarding our approach to sustainability matters and environmental, social and governance practices; competition in the apparel and fashion industry; our ability to attract and retain key personnel; seasonal and quarterly variations in our revenue and income; the protection and enforcement of intellectual property rights relating to the Vince brand; the extent of our foreign sourcing; our reliance on independent manufacturers; our ability to ensure the proper operation of the distribution facilities by third-party logistics providers; fluctuations in the price, availability and quality of raw materials; the ethical business and compliance practices of our independent manufacturers; our ability to mitigate system or data security issues, such as cyber or malware attacks, as well as other major system failures; our ability to adopt, optimize and improve our information technology systems, processes and functions; our ability to comply with privacy-related obligations; our status as a “controlled company”; our status as a “smaller reporting company”; and other factors as set forth from time to time in our Securities and Exchange Commission filings, including those described in our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. We intend these forward-looking statements to speak only as of the time of this release and do not undertake or revise them as more information becomes available, except as required by law.
About Vince Holding Corp.
Vince Holding Corp. is a global retail platform that operates the Vince brand women’s and men’s ready-to-wear business. Vince, established in 2002, is a leading global luxury apparel and accessories brand best known for creating elevated yet understated pieces for everyday effortless style. Vince Holding Corp. operates 42 full-price retail stores, 12 outlet stores, and its e-commerce site, as well as through premium wholesale channels globally. Please visit www.vince.com for more information.
About October’s Very Own
October’s Very Own (OVO) is a Canadian lifestyle brand led by CEO Drex Jancar and founded by Aubrey “Drake” Graham, Oliver El-Khatib, and Noah “40” Shebib. OVO offers premium apparel and accessories and is known for its distinctive owl logo and black-and-gold aesthetic. The brand has grown into a globally recognized enterprise with 12 flagship stores and a worldwide e-commerce presence.
About Authentic Brands Group
Authentic Brands Group (Authentic) is a global brand and entertainment platform that owns and invests in iconic intellectual property and cultural assets. It accelerates brands through a set of specialized businesses that combine powerful storytelling, premium content, unforgettable live experiences and global commerce. Through a network of more than 1,700 best-in-class licensees and strategic partners across 150 countries and expansive distribution, Authentic’s brands drive more than $38 billion in annual systemwide retail sales worldwide.
Authentic’s diversified portfolio spans more than 50 brands and reaches nearly one billion social media followers. Its roster includes Reebok, Champion, Shaquille O’Neal, David Beckham, Kevin Hart, Sports Illustrated, Elvis Presley, Muhammad Ali, Marilyn Monroe, GUESS, Care Bears, Aéropostale, Nautica, Eddie Bauer, Lucky Brand, Nine West, Brooks Brothers, Juicy Couture, Vince Camuto, Izod, Van Heusen, Dockers, Ted Baker, Hart Schaffner Marx, Vince, OVO, Barneys New York, Judith Leiber, Quiksilver, Spyder, Billabong, Volcom, Roxy, RVCA, DC Shoes, Prince, Sperry and Hunter.
CULVER CITY, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) — Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading independent global developer and publisher of interactive digital entertainment, showcased a broad portfolio of established intellectual properties, internally developed titles, major content launches, and upcoming releases during the first day of Gamescom 2026.
Snail Games CEO, Hai Shi, officially unveiled 9 Yin Sutra: Wuxia, an internally developed AAA title expanding the universe inspired by the Company’s Age of Wushu. The Age of Wushu IP now serves as the foundation for two creative universes: 9 Yin Sutra: Wuxia and 9 Yin Sutra: Immortal. While both titles originate from the same underlying IP, the games are being developed as distinct interpretations of that universe. 9 Yin Sutra: Wuxia draws more heavily from historical Wuxia traditions and represents the closest sequel to Age of Wushu, while 9 Yin Sutra: Immortal offers a more fantastical take on the fast-growing cultivation genre. This differentiated approach is intended to broaden the creative potential of the IP while providing each title with its own unique identity, setting, tone, and gameplay experience. Players can watch the Gamescom 2026 official announcement trailer and wishlist 9 Yin Sutra: Wuxia and 9 Yin Sutra: Immortal.
Snail Games also showcased For The Stars, another internally developed AAA title, through a new gameplay trailer and exclusive demos for members of the media attending Gamescom. The demos provided media with an opportunity to experience the game ahead of its broader release and offered additional insight into the title’s development.
The Company views internally developed titles For The Stars, 9 Yin Sutra: Wuxia, and 9 Yin Sutra: Immortal as an important component of its broader portfolio strategy, providing opportunities to develop new intellectual properties and expand existing franchises through proprietary development capabilities.
Snail Games also highlighted continued investment in its established portfolio. PixARK is officially launching its premium Terracrypt DLC, adding 200+ hours of new content to the survival sandbox experience. While ARK: Survival Ascended is launching a major ARK: Astraeos update alongside a new trailer, further expanding the ARK ecosystem.
Bellwright was featured at Gamescom with a new playable demonstration. The demo provides an early look at planned traversal features. The continued development of community inspired features is intended to expand player loyalty as the title progresses.
And Honeycomb: The World Beyond received an exclusive Gamescom showcase ahead of its September 8 launch. Gamescom attendees were given access to the latest playable demo, providing an opportunity to experience the game ahead of release. Players unable to attend Gamescom will also have an opportunity to experience the new demo, which is scheduled to become available on August 31, ahead of the game’s official launch.
Snail Games’ first day at Gamescom highlighted a portfolio strategy built around multiple avenues of growth: extending successful intellectual properties, launching new premium content, developing new titles internally, and expanding access through additional platforms and player experiences.
For creators interested in collaborations please contact [email protected].
About Snail, Inc. Snail, Inc. (Nasdaq: SNAL) is a leading global independent developer and publisher of interactive digital entertainment for consumers around the world, with a premier portfolio of premium games designed for use on a variety of platforms, including consoles, PCs, and mobile devices. For more information, please visit: https://snail.com/.
Forward-Looking Statements This press release contains statements that constitute forward-looking statements. Many of the forward-looking statements contained in this press release can be identified by the use of forward-looking words such as “anticipate,” “believe,” “could,” “expect,” “should,” “plan,” “intend,” “may,” “predict,” “continue,” “estimate” and “potential,” or the negative of these terms or other similar expressions. These forward-looking statements include information about possible or assumed future results of Snail Games’ business, financial condition, results of operations, liquidity, plans and objectives. Forward-looking statements appear in a number of places in this press release and include, but are not limited to, statements regarding the Company’s strategy of expanding established intellectual properties while investing in internally developed games and new experiences; the differentiated approach broadening the creative potential of the IP while providing each title with its own distinct identity, setting, tone, and gameplay experience; internally developed titles being an important component of Snail Games’ broader portfolio strategy; providing opportunities to develop new intellectual properties and expand existing franchises through proprietary development capabilities; continuing investment in the Company’s established portfolio; planned traversal features for Bellwright; launching Honeycomb: The World Beyond on September 8; the new demo becoming available on August 31; Snail Games’ portfolio strategy being built around multiple avenues of growth: extending successful intellectual properties, launching new premium content, developing new titles internally, and expanding access through additional platforms and player experiences; and assumptions underlying any of the foregoing. Further information on risks, uncertainties and other factors that could affect Snail Games’ financial results and business include Snail Games’ ability to develop new intellectual properties and expand existing franchises through its proprietary development capabilities; Snail Games’ ability to incorporate traversal features for Bellwright, crossplay integration across Steam, Xbox, and PlayStation and launch Honeycomb: The World Beyond and its new demo as planned; Snail Games’ ability to achieve multiple avenues of growth by extending successful intellectual properties, launching new premium content, developing new titles internally, and expanding access through additional platforms and player experiences; Snail Games’ ability to retain its key employees or maintain its Nasdaq listing; and the risks that are included in its filings with the Securities and Exchange Commission (the “SEC”) from time to time, including its annual reports on Form 10-K and quarterly reports on Form 10-Q filed, or to be filed, with the SEC. You should not rely on these forward-looking statements, as actual outcomes and results may differ materially from those expressed or implied in the forward-looking statements as a result of such risks and uncertainties. All forward-looking statements in this press release are based on management’s beliefs and assumptions and on information currently available to Snail Games, and Snail Games does not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
Investor Contact: John Yi and Steven Shinmachi Gateway Group, Inc. 949-574-3860 [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/summit-midstream-corporation-announces-final-investment-decision-on-double-e-pipeline-mainline-compression-expansion-302864529.html
